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Abbreviations 
 
A     Ampere 
acTEV protease    Enhanced Tobacco etch virus protease  
AFM     Atomic force microscopy 
Ag     Silver 
AOT     bis(2-ethylhexyl)sulfosuccinate 
Au     Gold 
Au/AgNP    Gold/silver alloyed nanoparticle 
AuND     Gold nanodot 
AuNP     Gold nanoparticle 
bp      Base pairs  
CFP     Cyan fluorescent protein 
Cu     Copper 
Cy3/5     Cyanine3/5 
Da      Dalton  
DMEM    Dulbecco’s Modified Eagle’s Medium 
DNA      Deoxyribonucleic acid  
dNTP      Deoxynucleosidetriphosphate  
eGFP     Enhanced green fluorescent protein 
F     Farad 
Fig     Figure 
FM     Fluorescence microscopy 
FP     Fluorescent protein 
FPLC     Fast-performance liquid chromatography 
FRET     Förster (or fluorescence) resonance energy transfer 
g     Gravitational acceleration 
GST     Glutathione S-transferase 
HA     Hemagglutinin 
HPLC     High-performance (or pressure) liquid chromatography 
h     hour 
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HRP      Horseradish peroxidase  
IgG     Immunoglobulin G 
LB     Luria-Bertani broth  
LSM     Laser scanning microscopy 
LSPR     Localised surface plasmon resonance 
min     Minute 
ND     Nanodot (nanosphere with a diameter less than 2 nm) 
NIR     Near-infrared 
nm     Nanometer 
NMR     Nuclear magnetic resonance 
NP     Nanoparticle (nanosphere with a diameter more than 3 nm) 
OD      Optical density  
PCR      Polymerase chain reaction  
pI     Isoelectric point 
PPI     Poly(propyleneimine) 
rPhiYFP Recombinant yellow fluorescent protein from Phialidium 
species 
RT      Room temperature  
SbsC Surface-layer protein from Geobacillus stearothermophilus 
species 
SDS-PAGE     Sodium dodecyl sulphate polyacrylamide gel electrophoresis  
SEM     Scanning electron microscopy 
SOC     Super optimal broth, catabolite repression medium 
TBE      Tris Borate EDTA  
TBS      Tris-buffered saline  
Tris      Tris(hydroxymethyl)aminomethane  
UV/Vis    UV/Visible light 
V      Volt  
v/v      Volume per volume  
W     Watt 
w/v      Weight per volume  
Ω     Ohm 
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Amino Acid Abbreviations 
 
1-Letter   3-Letter   Name 
A    Ala    Alanine 
C    Cys    Cysteine 
D    Asp    Aspartic acid (Aspartate) 
E    Glu    Glutamic acid (Glutamate) 
F    Phe    Phenylalanine 
G    Gly    Glycine 
H    His    Histidine 
I     Ile    Isoleucine 
K    Lys    Lysine 
L    Leu    Leucine 
M    Met    Methionine 
N    Asn    Asparagine 
P    Pro    Proline 
Q    Gln    Glutamine 
R    Arg    Arginine 
S    Ser    Serine 
T    Thr    Threonine 
V    Val    Valine 
W    Trp    Tryptophan 
Y    Tyr    Tyrosine 
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Aim of the work 
 
Usage of the peculiar properties of gold nanoclusters dates back as far as centuries B.C., when 
colloidal gold was used to decorate ceramics and later polychromatic glasses, and employed in 
medical treatments for various pathologies ranging from unstable mental and/or emotional states, 
to arthritis and tuberculosis. [Shaw C.F., 1999]. In 1857, Faraday reported the synthesis of 
“small” gold clusters via reduction from gold ions and a study about the optical properties of such 
clusters. In the recent decades, not only various synthesis methods for metallic nanoclusters have 
been developed, but also most of their optical and electronical properties have been illuminated. 
It is now clear that nanosized noble metal clusters demonstrate very different characteristics 
compared to bulk metals. Moreover, these properties earned them a place in many industrial 
applications. Perhaps the most notable and mostly researched property is the demonstration of 
surface plasmon resonance (SPR) and the strong absorption of electromagnetic radiation as a 
result of SPR. SPR has been so far utilised in chemical and bio-sensing, imaging, spectroscopy, 
and in targeted therapy [Phillips K.S. and Cheng Q., 2007]. 
 
Molecular fluorescence based measurements and devices are widely employed in fields such as 
chemistry, molecular biology, materials science, photonics, and medicine. Applications as varied 
as single molecule detection, automated DNA sequencing and examination of circulation in the 
heart and retina [Frangioni J.V., 2003] represent the vastness of the potential applications of 
fluorescence. Regardless of the nature of the application, most of such systems rely directly on 
the inherent brightness of the molecular fluorophore for the detection sensitivity [Tam F., et al., 
2007]. Especially, fluorophores with emission in the range between 500-700 nm have been 
proven to be valuable tools in biosensing/imaging for disease screening, diagnosis, and 
monitoring due to the fact that most biological systems generate autofluorescence noise 
minimally at these wavelengths [Berlier J.E., et al., 2003]. The ability to enhance the emission of 
such fluorophores is greatly desired in order to increase the sensitivity of detection and to reduce 
the signal to noise ratio. On the other hand, the ability to turn off or to quench the signal from a 
certain fluorophore might be advantageous in the case of multiple fluorescent tag employing 
assay systems. 
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It was first suggested by Purcell in 1946, that spontaneous emission could be modified by 
resonant coupling to the external electromagnetic field. Since then amplified and inhibited 
spontaneous emission have been observed from semiconductor quantum wells integrated into 
microstructures, photonic crystals, and fluorophores near metal surfaces and nanoparticles 
[Härtling T., et al., 2007]. 
 
For the detection of a biological molecule (an antigen) there are two mechanisms: the change of 
fluorescence signal from the bioconjugated nanoparticle, and the shift of the localised surface 
plasmon resonance (LSPR) of the gold nanoparticle. However, in such a hybrid system there are 
various additional processes which have a potential to influence the above mentioned signals. 
Firstly, the overlap of the excitation spectrum of the fluorophore and LSPR of the nanoparticle 
can cause an energy transfer which in turn can create additional resonances or cause the 
quenching of the fluorophore. Furthermore, the high electric field around the gold nanoparticle 
could yield to an enhancement of both mechanisms. Finally, there is also the possibility, that a 
change in the environment can pose an additional influence on the measured signal(s). A very 
critical application in that sense would be the application of such a bioconjugated gold 
nanoparticle employing assay for intracellular measurements, where the stability of the 
bioconjugates during intracellular delivery becomes important. 
 
In this work I tried to observe the effects of various noble metal nanoparticles on the emission of 
two fluorescent proteins, namely the enhanced green fluorescent protein (eGFP) and the yellow 
fluorescent protein (rPhiYFP); and to develop an example for an application of such a 
nanoparticle based fluorescence modifying in vitro system. Additionally the final part deals with 
the intracellular delivery and use of nanoparticles as fluorescence reporters in vivo. 
 
Formulated bioassay method 
 
The main intention of this work is to study the potential of bioconjugated gold nanoparticles for 
biosensing/bioassay applications, in which the interaction of an antigen is monitored in terms of 
plasmon peak shift and fluorescence change. The model is illustrated in the following scheme 
(Fig. 1). 
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Figure 1. Gold nanoparticles are functionalised with a specific antibody and the antigen is labelled with a 
fluorophore. Binding of the labelled antigen to the antibody will cause a shift in the plasmon peak. Upon 
introduction of the same antigen labelled with a different fluorophore, it is expected to get a further 
change in the plasmon peak and a change in the fluorescence signal. 
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1 Introduction 
 
1.1 Nanobiotechnology and Metallic Nanoparticles 
 
The word nanobiotechnology describes the use of nanotechnology in biological systems. 
Although the field itself is considered to be relatively new, nanotechnology is already having an 
impact in bioanalysis, where nanoparticles of various sizes, shapes, and compositions are being 
used to replace “traditional” bioanalysis schemes [Penn S.G., et al., 2003]. The field 
nanobiotechnology spans a vast area of application, and not all of the subfields necessarily 
involve the use of nanoparticles, which constitutes the backbone of this thesis. 
 
As stated above, the field of nanotechnology deals with research and technology development in 
the length scale range approximately 1 to 100 nm and designing and using systems and devices 
characterised by novel properties arising from their size and shape. Applicative uses of 
nanotechnology are in general still very limited, but nanoparticles have already found many 
industrial applications including: electronic, optoelectronic, biomedical, pharmaceutical, 
cosmetic, catalytic, and material areas and made their way into various products. 
 
The impressive range of interests and applications of nanoparticles arises from the versatility and 
tunability of their properties. It is well known that properties of bulk materials change as their 
size goes down to small aggregates, even down to a few atoms [Kubo R., 1962]. Metal and 
semiconductor bulk properties can be explained referring to electrons that occupy energy bands, 
whereas in single atoms electrons are distributed in discrete energy levels. When only a few 
atoms are linked together forming very small clusters with dimensions in the range of a few 
nanometers, their electronic configuration lays somewhat in between; it dramatically depends on 
the size of nanoparticles and can only be explained by quantum mechanics. In other words, the 
electronic (optical, electrochemical, magnetic, and catalytic) properties of nanoparticles differ 
from those of bulk materials because their valence electrons experience different energies and 
distributions [Li X.-B.., et al., 2007]. These properties of such small clusters depend not only on 
the material but also on their size and shape, besides the environmental conditions that their 
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surfaces experience. Furthermore, many different capping agents can be used to derivatise their 
surface tailoring their properties such as solubility or affinity [Bakshi M.S., et al., 2007]. 
 
Among the different kinds of nanoparticles, the ones consisting of gold are extensively studied 
for several reasons. First of all, their synthesis is straightforward. Secondly, they are very stable; 
perhaps the most stable among metallic colloids. Finally, they present very peculiar electronic, 
magnetic, and optical properties related to their size. 
 
1.1.1 Synthesis of gold and silver nanoparticles 
The first systematic synthesis of pure nanosized Au was introduced by Michael Faraday in 1857. 
In his classical work, Faraday reduced AuCl with phosphorous into Au nanoparticles. On the 
other hand, unlike the synthesis of Au nanoparticles, synthesis of Ag nanoparticles is 
conceptually rather new. As of now, a large number of well established methods for the synthesis 
of both nanoparticles have been made available [Biju V., et al., 2008]. Some of the most 
commonly used methods for NP synthesis are shown in Fig. 2. 
 
 
Figure 2. Some selected methods for Au and Ag nanoparticle synthesis. 
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1.1.2 Optical Properties of metallic nanoparticles and localised surface plasmon resonance 
(LSPR) 
Interaction of light with nanostructured metal films and nanoparticles, i.e. light waves coupled to 
free electrons on a metal surface, can give rise to hybrid surface waves, broadly termed as surface 
plasmons. The so-called surface plasmons demonstrate the ability to confine light at a 
metal/dielectric interface, which can either localise or propagate depending upon the 
dimensionality of the nanostructured material. The confinement of light, which is responsible for 
the peculiar optoelectronical properties of such nanomaterials, results from the collective 
oscillation of conduction electrons at the metal surface. The surface of a metallic nanoparticle 
contains free and mobile conduction electrons. In the presence of electromagnetic radiation, the 
free electrons are displaced by the electric vector and the columbic attraction between the 
electron cloud and nuclei becomes the main restoring force. As a result of the oscillating nature 
of the electric field of light, the electron clouds coherently oscillate over the surface with a ceratin 
resonance frequency. Nanostructured systems of noble metals such as silver and gold are of great 
interest since their localised surface plasmons resonate at the optical wavelength of 
electromagnetic radiation [Pastoriza-Santos I., et al., 2006 and Talley C.A. et al., 2005]. 
 
The surface plasmons are broadly classified as propagating surface plasmons and localised 
surface plasmons. Propagating surface plasmons (often called surface polaritons) are associated 
with smooth, thin films of gold and silver wherein the plasmon feels a boundary due to the planar 
surface. The surface plasmon in such a metal/dielectric interface has a combined electromagnetic 
wave as well as surface charge character and is highly bound to the surface (Fig. 3A). As a result 
of the combined character, an enhanced field is observed near the surface in the perpendicular 
direction, the amplitude of which decays exponentially with the distance from the surface and is 
said to be evanescent or near-field in nature. Once surface plasmons are generated on a flat metal 
surface they can propagate, however they gradually attenuate due to the loss arising from the 
absorption in the metal. This can be minimised using several methods, however, since this type of 
surface plasmons are not within the scope of this work, more detail will not be presented. The 
phenomenon of propagation, serving the basis behind the ability of such nanostructures to trap, 
concentrate, and channel light has potential applications in optical devices, spectroscopy, 
chemical and biosensing [Barnes W.L., Dereux A. and Ebbesen T.W., 2003]. 
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A B
 
Figure 3. Surface plasmons at the interface between a metal and a dielectric material having a combined 
electromagnetic wave and surface charge character. Picture taken from Barnes W.L., Dereux A. and 
Ebbesen T.W., 2003 (A); Schematic illustrating a localised surface plasmon. Picture taken from Willets 
K.A. and Van Duyne R.P., 200/ (B). 
 
In contrast to the propagating nature of surface plasmons on a planar metal/dielectric interface, 
the electron plasma in metal nanoparticles is contained in a finite volume, which is smaller than 
the wavelength of light. Localised surface plasmons originate from the collective oscillation of 
free electrons, confined at the surface of metallic nanoparticles, when excited with 
electromagnetic radiation (figure 3B). Unlike bulk materials, the surface plasmons in metallic 
nanoparticles, especially Ag, Au, and Cu, can be directly excited by light in the visible region. 
Absorption of electromagnetic radiation occurs when incident photon frequency is in resonance 
with the collective oscillation of the conduction electrons, resulting in unique optical properties. 
In 1908, Gustav Mie provided a quantitative description of the resonance for spherical particles 
[Liou K.-N., 1977]. According to Mie theory, the total cross section consists of scattering and 
absorption (often referred to as extinction) and is given as summation over all electric and 
magnetic oscillation. The contribution of absorption and scattering mainly depends on the size 
and shape of the particles and the dielectric constant of the medium (Fig. 4 and 5) [Pal A., et al., 
2004]. 
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Figure 4. (a) Calculated spectra of optical extinction efficiencies for gold nanoparticles with three 
different radii (20, 40, and 60 nm) as a function of the relative wavelength shift in response to the 
refractive index change in surrounding medium from 1.34 to 1.7. (b) Size dependence of the SPR 
wavelength response to change in the refractive index of the surrounding medium. The sensitivity is 
estimated from the slope of this linear plot. [Figures taken from Lee K-S. and El-Sayed M.A., 2006] 
 
 
Figure 5. Extinction spectra of gold nanoparticles: a) 23-nm-diameter spheres, b) 70-nm-diameter 
spheres, c) hexagons, d) cubes, e) rods (aspect ratio ~4.4), f) rods (aspect ratio ~16) [Figures taken from 
Orendorff C.J., et al., 2006]. 
 
 
1.1.3 Binding proteins to nanoparticles and evidencing the binding event 
With the recent development of biotechnology, bioconjugates of nanoparticles have received 
considerable research interests because the obtained hybrid biomaterials own unique properties 
provided by the gold nanoparticles. The stabilization and functionalisation of gold nanoparticles 
with a biomolecular recognition motif have provided flexibility for a variety of applications, 
including bioassays, bioimaging and biosensing. As a result, the ability to synthesize aqueous-
stabilized nanoparticles of controlled size and shape that can be easily functionalized with 
biomolecules (peptides, enzymes, antibodies, DNA) is highly desirable. 
Introduction 
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It is well established that many functionalities can bind to metallic gold, including sulphur-
containing moieties such as thiols, thioethers, thioesters, disulfides, isothiocyanates, and then 
phosphines, amines, citrate, carboxylates, yielding, in all cases, a passivation of the surface that 
stabilizes nanoparticles preventing their coalescence, although each of these confer a different 
degree of stability. 
 
For the validation and demonstration, of whether above-mentioned organic molecules used as 
capping agents are actually bound to the nanoparticle surface, several methods are available. 
These methods rely on the fact that the capping process is based on the interaction of the 
approaching molecules with the electrons of the external atoms of the nanoparticles, inducing 
rearrangements of their electron density. Therefore, upon successful binding, the NMR spectra of 
the molecules adsorbed on the surface are altered [Thomas K.G. et al., 2002].  
 
However, the most straightforward ways to probe molecular binding to the surface are 
photophysical techniques, i.e. UV/Visible absorption measurements. The ligands on the 
nanoparticle surface demonstrate a refractive index or dielectric constant change in the immediate 
vicinity of the nanoparticle surface and therefore perturb the shape and position of the localised 
surface plasmon band (LSPB), which - as explained above - is determined by free electrons 
occupying the outer conduction band [Kreibig U. and Vollmer M, 1995]. The capping moieties 
are expected to cause a shift of the LSPB as compared to uncapped nanoparticles, and the 
changes are expected to be larger with increasing strength of the binding event. There are two 
ways to evaluate changes in the plasmon spectra caused by target binding: wavelength change of 
the plasmon peak or extinction/absorption intensity change at a fixed wavelength [Englebienne 
P., et al., 2000]. In the case the plasmon peak upon target binding is very small due to low 
signal/noise ratio the latter is often used as an indicator. However, the second approach has an 
inherent problem: the change in extinction intensity could also occur due to a change in particle 
concentration, i.e. because of several washing steps, contributing to the noise. Therefore, the 
wavelength shift of the plasmon band has a greater potential for biosensing [Marinakos S.M., et 
al., 2007]. For an example of this kind of a sensor and plasmon band shift please refer to section 
1.3.1.2 
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1.1.4 Formular expression of dependency of LSPR peak on the dielectric constant of the 
medium 
The LSPR peak depends on the refractive index of the surrounding medium (n) and can be 
determined by the following equation [Mulvaney. P., 1996]: 
   ( )mp
d
c
εελ
π
λϖ
λ 2
)
4
1(
2
22
22
2
+=⋅+
∞     (Eq. 1) 
 
where, λP is the bulk plasma wavelength, ε∞ is the high-frequency dielectric constant due to 
interband and core transitions, dϖ  is the relaxation  or damping frequency, c  is the vacuum light 
velocity, and εm is the dielectric constant of the medium, which is related to the refractive index 
of the medium by the following formula: 
 
  n = (εm)1/2        (Eq. 2) 
The particle size R  influences the damping frequency dϖ . It depends on an effective radius effR  
as 
  
eff
Fermi
d R
v=ϖ    with  
MFPeff RRR
111 +=    (Eq. 3)  
where MFPR  is the mean free path of the electrons in the bulk material.  
For small damping frequency (large particles) with 1
2
<<
eff
Fermi
cR
v
π
λ
equation 1 tends to  
   λ2 = λP2(ε∞ + 2εm)      (Eq. 4) 
describing the plasmon resonance for the bulk material. Equation 1 and equation 4 hold true for 
Au nanoparticles lacking a capping agent. However, in most of the cases Au nanoparticles are 
stabilised by capping agents in solutions. By involving the contribution of the monolayer, 
equation 4 was modified as follows [Templeton A.C. et al., 2000]: 
 
 λ2 = λP2{ε∞ + 2εm + [2g(εs - εm)/3]}      (Eq. 5) 
 
where, εs is the dispersionless optical dielectric function of the shell (capping agent), g is the 
volume fraction of the shell layer. For very small Au nanoparticles, the equation relating to the 
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position of the LSPR peak is given by equation 5; and according to that formula the size of the 
core and organic shell becomes comparable and g value is large. Therefore, the solvent refractive 
index effect is quite small for Au nanoparticles with a diameter less than ~2 nm and it becomes 
more important with increasing nanoparticle diameter. 
 
 λ2 = λP2{ε∞ + 2εs + [2f εs(εm – εs)/(εs + 2εm)]}    (Eq. 6) 
 
where, f is the core volume fraction and is represented by: 
 
 f = (1 – g)         (Eq. 7) 
 
For values of f = (1 – g) = 0.05, the surface plasmon mode remains constant at a certain value and 
loses its sensitivity to solvent refractive index changes. 
 
1.1.5 Bimetallic silver-gold alloy nanoparticles 
Alloy nanoparticles exhibit unique electronic, optical, and catalytic properties that are different 
from those of the corresponding individual metal nanoparticles [Kariuki N.N., et al. 2004]. Their 
chemical and physical properties can be tuned by varying the composition and atomic ordering as 
well as the size of the clusters. Nanoalloys may not only demonstrate “magic sizes” but also 
“magic compositions”, i.e., sizes and compositions at which the alloy nanoparticles present a 
special stability. Surface structures, compositions, and segregation properties [Ruban A.V., et al., 
1999] of nanoalloys are also of interest as they are important in determining chemical reactivity 
and especially catalytic activity. 
 
Nanoalloys might also exhibit certain properties due to finite size effects, e.g., pairs of elements 
(such as iron and silver) which are immiscible in the bulk but readily mix in finite clusters 
[Andrews M.P. and O’Brien S.C., 1992]. 
 
Bimetallic nanoalloys can be generated with, more or less, controlled size and composition 
(figure 6). The nanoparticle structures and degree of segregation of the atoms making up the 
nanoalloy or mixing may depend on the method and conditions of cluster generation (type of 
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cluster source, temperature, pressure, etc.). Nanoalloys can be generated in a variety of media, 
such as cluster beams, colloidal solutions, immobilized on surfaces, or inside pores. 
 
 
 
Figure 6. Snapshots from the 38-atom Ag-Au sequence. Light and dark gray spheres correspond to Ag 
and Au atoms, respectively. In the first row, the first two global minima of the sequence are truncated 
octahedral structures, while a core-shell disordered structure is located at Ag35Au3. In the box, the cluster 
Ag32Au6 is the perfect sixfold pancake, and this perfect structure is the best up to Ag26Au12. Thereafter, all 
the global minimum structures are truncated octahedra, with silver atoms preferentially occupying vertex 
or edge positions [picture taken from Rossi G., et al., 2005]. 
 
Most of the experimental interest has centered on the optical properties of silver-gold nanoalloys; 
for example, how the shape and frequency of the plasmon resonance of Ag-Au nanoparticles vary 
with composition and the degree of segregation or mixing [Kreibig U. and Vollmer M., 1995]. In 
addition to the optical applications, there is also interest in improving the selectivity of the 
activity of silver or gold counterpart, for instance the differences in the DNA binding capability 
of silver and gold counterparts of an alloyed nanoparticle. Core-shell type particles can also be 
generated by chemical or electrochemical deposition of one metal onto a preformed cluster of the 
other. Optical measurements on these core-shell nanoparticles have revealed that the surface 
plasmons of the bimetallic nanoparticles are broad and complex. On the other hand, intermixed 
Ag-Au nanoparticles show a single plasmon resonance, as for pure metals. For intermixed 
clusters of fixed size, experiment and theory agree that the plasmon peak varies smoothly with 
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composition between that of pure Ag and pure Au nanoparticles: red shifting with increasing Au 
content (figure 7) [Bruzzone S., et al., 2003]. Alloyed Ag-Au nanoparticles also demonstrate 
increasing plasmon frequency with decreasing size, with the rate of increase of frequency being 
intermediate between that of pure large Au and pure small Ag nanoparticles [Voisin C., et al., 
2000].  
 
 
Figure 7. Calculated absorption cross-section versus wavelength for Au-Ag alloyed nanoparticles with 
different relative Au composition. With the increasing Au content, the absorption peak shifts towards red 
[picture taken from Jian Zhu, 2005]. 
 
Experimentally, it is challenging to obtain detailed internal structural information for bimetallic 
Ag-Au nanoparticles. Due to the small difference in the lattice constants of Ag and Au, direct 
lattice imaging using high resolution electron microscopy is not very informative. For particles 
with a diameter of 10 nm or above, chemically sensitive diffraction contrast can be used to 
determine the elemental separation inside the particles by making use of the difference in the 
extinction distances in Ag and Au metals [Srnová-Sloufová I., et al., 2000]. 
 
1.1.6 Autofluorescent gold nanodots 
Autofluorescence from gold nanoparticles was predicted to some degree as early as in 1969 
[Mooradian A., 1969]. After some studies relating the fluorescence to roughness and other factors 
[Boyd G.T., et al., 1986], the phenomenon was finally correlated to the electronic structure only 
in 1988 [Penn D.R. and Apell P., 1988]. Excitation was then related to transitions from occupied 
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d bands to states higher in energy. On the other hand, emission was related to the reoccupation of 
the hole created by the excitation of the d band electron with another from an occupied sp band. 
 
In one of the earliest synthesis of autofluorescent germanium colloids stabilized with 
nonfluorescent moieties, a quantum yield of 10-4-10-5 for the emission observed at 440 nm upon 
excitation at 230 nm was reported [Wilcoxon J.P., et al., 2001]. By the use of size-exclusion 
liquid chromatography, size-dependency of the fluorescence was investigated, showing that no 
fluorescence was detectable for clusters exceeding a diameter of 5 nm; which suggests that 
quantum effects are important in the autofluorescence of such metallic nanoparticles. 
 
Higher quantum fluorescence efficiency was reported for water soluble, 1.8 nm diametered gold 
nanoclusters, which are protected with tiopronin thiolate [Huang T. and Murray R.W., 2001]. The 
same authors also investigated the fluorescence by varying the thiolate ligands in order to relate 
the fluorescence to the protecting agent. It was found that the fluorescence band energy and 
intensity were affected by the nature of the protecting agent. 
 
Although certain parameters, on which the fluorescence of gold nanoclusters depends, have been 
identified, the exact mechanism of this phenomenon is yet to be clarified. Most of the systems 
reported in the literature, even the apparently similar ones, present very different photophysical 
properties and the various authors explain them suggesting different models. However, it is 
believed that the phenomenon is due to the transitions within different electronic levels in the 
broadest sense. 
 
1.2 Optical Interaction of Nanoparticles with Fluorescent Molecules 
Metallic nanoparticles are known to drastically modify the spontaneous emission of nearby 
fluorescent molecules and materials [Tam F., et al. 2007]. Over the past few years, research has 
focused on determining the form, the extent, the fundamental properties underlying, and the 
parameters affecting the modification. Especially enhancement of molecular fluorescence has 
been of great interest due to the widespread popularity of molecular fluorescence based 
measurements and devices. Applications spanning diverse range of fields such as chemistry, 
molecular biology, materials science, photonics, and medicine all rely directly on the inherent 
brightness of the molecular fluorophore for detection sensitivity [Weiss S., 1999 and Painter O., 
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1999]. Two examples to such methods are single molecule detection and automated DNA 
sequencing. 
 
The fluorescent emission of molecules can be influenced by metallic nanoparticles in several 
ways: 
1. By enhancing the optical intensity incident on the molecule via near field enhancement: At 
the plasmon resonance wavelength of a metallic nanoparticle, the light intensity in the near 
field of the nanoparticle is enhanced strongly relative to the incident optical wave [Dulkeith, 
E., 2002]. 
2. By modifying the radiative decay rate of the molecule [Kitson S.C., et al., 1995 and Aslan K., 
et al., 2005]. 
3. By increasing the coupling efficiency of the fluorescence emission to the far field through 
nanoparticle scattering [Szmacinski H., et al., 2005]. 
 
1.2.1 Quenching of fluorophores linked to nanoparticles 
One of the best defined types of fluorescent signal modification documented in the literature is 
the quenching of fluorescence by the presence of nanoparticles in the vicinity. In 1999, Murray 
and co-workers demonstrated the strong quenching of the emission from the fluorescein moiety 
by spectrofluorometric measurements when 5-(aminoacetoamido)-fluorescein was bound to 
tiopronin protected gold nanoparticles. One year later in the same group the dependence of 
quenching on the distance between the fluorophore and gold nanoparticle was demonstrated, 
simply by stabilizing the gold nanoparticles with a mixed monolayer of alkanethiolate and 
alkanethiolate derivatised with fluorescent dansyl groups and then varying the length of the alkyl 
linker and monitoring the fluorescence. [Templeton A.C., et al., 1999] Their results indicated a 
less efficient energy transfer and hence a reduced quenching with increasing linker length. 
Several other similar reports eventually indicated that the fluorescence quenching is neither due 
to competitive absorption by the gold cluster nor to an enhanced intersystem crossing efficiency, 
but to a quick deactivation of the excitation energy through electronic coupling of the excited 
fluorescent group with the nanoparticle [Canepa M., et al., 2003]. 
 
Another group worked with the fluorescent dye Cy5 attached to gold nanoparticles by single 
stranded DNA oligonucleotides functionalized with thiol groups. By time-resolved 
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photoluminescence spectroscopy they determined the values of radiative and nonradiative decay 
rates of the fluorescence that was suppressed by 95%. The photoluminescence quantum 
efficiency is distance dependent, and the radiative rate decreases monotonically with decreasing 
distance while the nonradiative one increases [Dulkeith E., et al., 2005]. These experimental 
results demonstrate that in the case of Cy5 dyes the luminescence quenching is almost 
exclusively due to a phase induced suppression of the radiative rate while energy transfer is of 
minor importance. 
 
Other studies have concerned the core size effects on the photophysical properties of appended 
chromophores [Imahori H., et al., 2003; Canepa M., et al., 2003]. They all agree that for gold 
nanoclusters, the efficiency of their electronic coupling with fluorophores does not depend on the 
size of the metal core, as long as it spans over at least 5 to 10 nanometers. 
 
It is worth underlying that it is possible to influence the different excited state deactivation 
pathways in these nanosystems by changing the appended chromophore. This means that each 
single system has its own specific properties arising from its components and their peculiar 
interactions in the assembly. Therefore, it is not possible to spot general behaviours but, at the 
same time, this is the basis of their versatility, one of the most valuable characteristics of metallic 
nanoparticles. 
 
1.2.2 Nonquenched fluorophores linked to nanoparticles 
The phenomenon which takes place when fluorophores are linked to or reside in the vicinity of 
metallic nanoparticles is not only quenching of the fluorescence; enhancement of the fluorescent 
signal by the metallic nanoparticles is another widely investigated event. 
 
One of the first reported observations of fluorescent signal enhancement by nanoparticles was by 
Thomas and Kamat in 2000 [Thomas K.G. and Kamat P.V., 2000]. 1-Methylaminopyrene was 
attached on gold clusters (with diameters ranging from 5 to 8 nm), weakly stabilized by 
tetraoctylammonium bromide moieties. In the resulting system, an intense emission was detected, 
while the nanoparticles are nonfluorescent and the 1-methylaminopyrene in the buffer used was 
weakly luminescent. It was then hypothesized that the interaction of the amino lone pair electrons 
of the fluorophore with the metal decreases the donating ability of the fluorophore and hence 
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suppresses the photo-induced electron transfer responsible for the main nonradiative decay 
process. 
 
Another interesting observation was the increase of the fluorescence lifetime of a fluorophore 
strongly bound to gold nanoparticle surface [Hernandez F.E., et al., 2005]. Fluorophore, 4-
acetamido-4’-maleimidylstilbene-2,2’-dithiol (AMDT)-functionalized gold nanoparticles (with 
average diameter of 3.5 nm) were synthesized by following the method proposed by Brust and 
Schiffrin (1994). The fluorescence lifetime of the excited state of the AMDT was enhanced when 
it was very close to the noble metal nanoparticle surface. No decrease of the fluorescence 
quantum yield could be measured and this indicates a weak energy transfer between the metal 
and AMDT in this organic-inorganic system. 
 
1.3 S-Layer Protein SbsC 
Surface layers, termed S-layer, comprise the outermost cell envelope component of most archaea 
and many bacteria; and serve various functions, including protective coats, molecular sieves (in 
the ultrafiltration range), ion or molecule traps, structures involved in cell surface interactions, 
and as antifouling coats. Furthermore, they are involved in determining the cell shape, and they 
contribute to virulence [Sara M., et al., 2005]. S-layers are composed of a single protein or 
glycoprotein species, which crystallize into oblique, square, or hexagonal symmetry 
demonstrating lattices [Pavkov T., et al., 2008]. The S-layer subunits are held together and linked 
to the underlying cell envelope by non-covalent bonds. Those lattices are highly porous and the 
pores are of identical size and morphology with diameters in the range of 2 – 8 nm [Sara M., et 
al., 2005]. After isolating from the cell wall, S-layer subunits mostly maintain the ability to self-
assemble in suspension, at air-water interface, on artificial solid supports, and on substrates 
covered with secondary cell wall polymers in vitro [Sleytr U.B., et al., 2007]. The ability to 
assemble in vitro and to form isoporous structures with functional groups located on the surface 
in an identical position and orientation, have led to the applications of S-layers as ultrafiltration 
membranes, immobilization matrices for functional molecules, conjugate vaccines, and as 
patterning elements in molecular nanotechnology [Sleytr U.B., et al., 1994]. 
 
A gram-positive bacterial species, Geobacillus stearothermophilus, representing one of the best 
studied S-layer systems, can produce at least five different S-layers depending on the 
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environmental conditions. The cell surface of G. stearothermophilus strain ATCC 12980 is 
completely covered with an oblique lattice formed by the S-layer protein SbsC [Egelseer E.M., et 
al., 1996]. The protein precursor includes a 30 amino acid signal peptide typical for gram-
positive bacteria, and consists of 1099 amino acids, with a molecular mass of 112.5 kDa and an 
isoelectric point of 5.5 [Jarosch M., et al., 2000]. 
 
1.4 Bioassays Employing Plasmon Shift and Fluorescence 
 
1.4.1 Use of metallic nanoparticles in biosensing 
The unique properties of noble metal particles, which have been explained above and which have 
attracted much attention in certain research fields such as medicinal imaging, thermal and/or 
nonthermal therapy, drug delivery, etc. have also attracted interest in biosensing. The main 
advantages are the precision, simplicity, and rapidity of such tests. Historically speaking, 
aggregation based detection have enjoyed much clinical and commercial succees since the 
development of the latex agglutination test (LAT) in 1956 [Singer J.M. and Plotz C.M., 1956]. In 
the LAT and similar agglutination based tests, specific antibodies are conjugated to latex 
microspheres or gold nanoparticles which, when mixed with a solution containing the target 
antigen, cause the microspheres/nanoparticles to form visible aggregates. Whereas this type of 
analysis is effective and rapid, it is relatively insensitive, relying on high concentrations of 
analytes and on human eye as the detector [Stuart D.A., et al., 2005]. 
 
Another means of detection utilising gold nanoparticles takes advantage of localised surface 
plasmon resonance (LSPR) of gold nanoparticles. This type of measurement is dependent on the 
strong UV/Vis absorption band at the LSPR wavelength. The assay we tried to prepare in this 
study lies in this category, and therefore a more detailed background will be given. However, it is 
noteworthy to discuss about a relatively newer approach, namely the scatter based sensing, before 
going deeper into LSPR based detection, which still is the backbone of nanoparticle based 
detection/biosensing. 
 
1.4.1.1 Scattering-based properties of plasmonic nanoparticles and scatter-based biosensing 
When a metallic nanoparticle is exposed to an electromagnetic wave, the plasmons (i.e. the 
electrons on the outer surface) start to oscillate at the same frequency as the incident wave; which 
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is followed by the emission of electromagnetic radiation by the oscillating electrons at their 
frequency of oscillation. This reradiation of light at the same incident wavelength is often 
referred to as plasmon scatter [Yguerabide J. and Yguerabide E.E., 1998]. 
 
As stated above, the number of reports on plasmon light scattering based sensing is smaller than 
on absorption-based sensing. Similar to absorbance-based measurements, plasmon supporting 
colloids also red-shift their scattering spectra as a function of coupling to other close proximity 
colloids. By taking the ratio of the scattered intensities at two different wavelengths, it is possible 
to measure, whether a given biospecies causes the aggregation or dissociation of the 
nanostructures. An example of such a system for glucose sensing was described by Aslan K. and 
Lackowicz J.R. in 2005. 
 
1.4.1.2 Absorption-based (or LSPR-based) biosensing 
The first type of signal transduction in this type of sensing depends on the sensitivity of the 
surface plasmon to interparticle coupling. When in a solution, interparticle spacing becomes less 
than the nanoparticle diameter, nanoparticles are able to interact electromagnetically by a dipole 
coupling mechanism. This readily leads to a broadening and red-shifting of the LSPR. Several 
papers have been published on a gold nanoparticle based UV/Vis technique for the detection of 
DNA. This detection method relies on the absorption spectra as particles are brought together by 
the hybridisation of complementary strands of DNA [Elghanian R., et al., 1997]. More recently, 
gold nanoshells functionalised with specific antibodies have been used to detect antigens in 
whole blood. Upon addition of the nanoshell conjugates to whole blood containing the antigen, 
the plasmon resonance broadens, the intensity decreases and a red-shift in the LSPR occurs 
[Hirsch L.R., et al., 2003]. The group reports this system to be capable of detecting 
pictogram/millilitre quantities of antigens within 30 minutes. However, the main disadvantage of 
the system is the risk of aggregation of nanoparticles, which is often irreversible, difficult to 
quantify, and interferes with the measurement. 
 
The first report of using an LSPR wavelength-shift measurement for sensing the local refractive 
index change owing to antigen-antibody binding came in 1998 from Englebienne. In that study, 
anti-human heart fatty acid binding protein (hFABP) monoclonal antibodies were adsorbed onto 
gold nanoparticles with various diameters by charge adsorption at pH 8.5; followed by incubating 
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the gold-connected antibodies with recombinant hFABP and the UV/Vis spectra were measured. 
They observed a significant LSPR shift, which cannot be attributed to agglomerization, which 
was the case in the above two examples, since the antibodies used were monoclonal and the 
recombinant hFABP contains a single epitope, ruling out the possibility of the formation of 
nanoparticle-protein matrices (figure 8). The LSPR shift is therefore hypothesized to result from 
the refractive index change of the individual particles upon antigen-antibody binding 
[Englebienne P., 1998]. This demonstrates that a significant spectroscopic change, i.e. LSPR 
shift, in a bioassay employing nanoparticles does not necessarily require the agglutination of 
nanoparticles; refractive index or dielectric constant change of the surrounding medium upon 
antigen-antibody binding is strong enough to yield a significant change. The sensitivity of 
measurement is still retained without giving up the simplicity and rapidity of the measurement. 
Furthermore the unknown contribution introduced by the agglutination is eliminated. 
 
 
Figure 8. Shift of the SPR (closed circles, solid curve, left axis) peak and absorbance decrease (closed 
triangles, dotted curve, right axis) of colloidal gold particles coated with a monoclonal anti-hCG antibody, 
calculated from visible spectra recorded after incubation of a fixed amount of the colloidal gold reagent 
with samples containing increasing concentrations of hCG [figure taken from Englebienne P., et al., 
1998]. 
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Another extension of LSPR sensing is carried out by aligning nanoparticles into well-defined 
arrays on solid support. Since this type of assays does not lie within the scope of this study a 
detailed description will not be presented here. 
 
1.4.2 Use of fluorescence in biosensing 
After discovery of the green fluorescent protein (GFP) in Aequorea Victoria [Prendergast F.G. 
and Mann K.G., 1978], cloning and subsequent expression in heterologous systems and 
generation of recombinant variants exhibiting stronger emission, stability, etc., GFP has become 
one of the mostly employed reporters for the analysis of gene expression and protein localisation 
among many other possible uses in a variety of experimental systems. 
 
One of the remarkable features of GFP is that it is a naturally fluorescent protein, encoding the 
light-emitting chromophore within its primary amino acid sequence. The GFP chromophore 
consists of a cyclic tripeptide derived from Ser-Tyr-Gly at positions 65-67 in the protein and is 
only fluorescent when embedded within the fully folded complete GFP molecule [Cody C.W., et 
al., 1993]. A number of variants of wild type GFP have been described by several authors, most 
of which contain one or more amino acid substitutions in the chromophore region of the protein 
[Kain S.R., 1999]. One of the two most commonly used GFP variant, which we also used in our 
study, is enhanced GFP (eGFP). It contains two amino acid substitutions: Phe at position 64 
substituted by Leu and Ser at position 65 by Thr. eGFP coding sequence has been further 
modified with 190 silent base changes to contain codons that are preferentially found in highly 
expressed human proteins. Advantages of eGFP include improved sensitivity of detection, 
improved solubility, more efficient protein folding, faster chromophore oxidation to form the 
fluorescent form of the protein and reduced rates of photobleaching [Patterson G.H., et al., 1997]. 
The following image (Fig. 9) shows the excitation and emission maxima of some GFP variants 
including eGFP. 
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Figure 9. Relative excitation (absorption) and emission (brightness) spectra for the five green fluorescent 
protein (GFP) mutant classes. Purified recombinant protein was used to generate the spectra. Y-axis 
values are set relative to rPhiYFP (100%) [picture taken from Cubbitt A.B., Woollenweber L., and Heim. 
R., 1999]. 
 
However, long before the discovery of GFP and its variants, fluorescence (for instance 
fluorescent dyes) has been used in biosensing due to several advantages: 
• High sensitivity 
• Non-invasiveness 
• Measurements can be made not only of fluorescence intensity but also of fluorescence decay 
times. Time-resolved fluorescence has the special advantages for in vivo sensing of being 
relatively independent of light scattering in the tissues and of fluorophore concentration, thus 
correcting for photobleaching or fluorophore loss mediated by diffusion or degradation 
[Szmacinski H., et al., 1994]. 
• Special fluorescence techniques can provide information about the structure and micro-
environment of molecules, and how these change in response to analyte variations in health 
and disease [Zhang Q., et al., 2004]. 
• The structure and distribution of biomolecules can also be probed by the phenomenon of 
fluorescence (or Förster) resonance energy transfer (FRET). 
 
Currently, there is no universally accepted classification system for sensor systems employing 
fluorescence; according to a recent review by VanEngelenburg and Palmer (2008) such systems 
can be divided into three classes: (i) Sensors in which protein activity or ligand binding alters 
FRET between two fluorescent proteins (fig 10 a, b, c, and d). (ii) Sensors which rely on 
modulation of the optical properties of a single fluorescent protein upon ligand binding (fig 10e). 
(iii) Sensors in which ligand binding causes the translocation of the fluorescent reporter (fig 10b). 
The following figure (Fig. 10) highlights the differences in these classes. 
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Figure 10. Platforms for fluorescent biosensor design. (a) Ligand induced conformational change 
platforms respond to intracellular ligand concentrations and ‘hinge’ open or closed to bring the fluorescent 
proteins (FP) in close proximity for FRET. (b) Sensors responding to specific protease activity contain a 
consensus peptide motif recognized by their cognate protease and dequench fluorescence from the donor 
FP. These sensors represent an essentially irreversible class of biosensor. (c) Kinase biosensors report the 
phosphorylation status of a model kinase substrate. Phosphorylation of a consensus peptide motif 
promotes intramolecular binding to a phosphopeptide-binding domain. (d) GTPase sensors utilize protein 
domains which selectively interact with the GTPase in the ‘ON’ or GTP bound state yielding FRET 
changes. (e) Biosensor designs using single fluorescent protein platforms: (i) pH and halide detection 
using fluorescent proteins engineered such that ligand-binding induce a spectral shift in the chromophore 
and (ii) circularly permuted fluorescent protein sensor appended to proximal ligand-binding domains 
which induces a spectral shift upon ligand-binding [picture taken from VanEngelenburg S.B. and Palmer 
A.E., 2008]. 
 
1.5 Intracellular Delivery of Gold Nanoparticles 
Intracellular delivery of gold nanoparticles has gained interest in the ongoing research in the 
nanotechnology field. Gold nanoparticles have been extensively studied as carriers of various 
bio-active molecules (peptides, proteins, DNA, etc.) through the cell membrane into the cells due 
to the importance of such delivery of bio-active molecules in medicine and drug delivery. 
Vehicles for intracellular delivery can be broadly classified into four major groups: viral carriers, 
organic cationic compounds, recombinant proteins, and inorganic nanoparticles. Although the 
former three have been investigated for a longer time, they have some disadvantages such as 
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being expensive, (highly) toxic, or immunogenic. On the other hand inorganic nanoparticles 
possess versatile properties suitable for this task, including availability, functionality, high 
biocompatibility, potential capability of targeted delivery and controlled release of cargo [Xu 
Z.P., et al., 2006]. 
 
1.5.1 Motivations of intracellular delivery of nanoparticles 
Recent advances in the nanotechnology field is causing a slow replacement of photothermal 
therapy methods, which employ light absorbing dyes for achieving photothermal damage to 
tumors, and photodynamic methods, which employ chemical photosensitizers that generate 
singlet oxygen that is capable of tumor destruction, by noble metal nanoparticles. Nanoparticles 
demonstrate a very strong absorption at their plasmon resonance peak, which is at least several 
times higher than that of conventional photoabsorbing dyes. This enables the use of laser 
irradiations at lower intensities, making the therapy minimally invasive. Furthermore gold 
nanoparticles have higher photostability and do not suffer from bleaching [Huang X., et al., 2007; 
Gannon C.J., et al., 2008]. One of the pivotal examples of this application is the in vitro selective 
killing of breast cancer cells treated with gold/silicon dioxide nanoshells targeted against them 
and irradiated at near infrared [Lowery A.R., et al., 2005]. 
 
A rather recently emerging application of gold nanoparticles is in the cancer treatment field, still 
different from the photothermal therapy explained above. It was documented that gold 
nanoparticles inhibit the proliferation of endothelial cells induced by VPF/VEGF (vascular 
permeability factor/vascular endothelial growth factor – the main protein factor responsible for 
the growth of new blood vessels into the tumorigenic tissue in vivo). Gold nanoparticles bind to 
the VPF/VEGF to inhibit its activity, successfully blocking neovascularisation [Mukherjee P., et 
al., 2005]. The exact mechanism of inactivation is not yet clear. In the case of VPF/VEGF, it has 
been determined that for the interaction between the protein and nanoparticle as well as for the 
inactivation of the protein, the heparin binding domain of VEGF/VPF is crucial. However, it is 
still not known, whether the effect is due to the charge distribution change of the whole protein, 
or the charge distribution change within the heparin binding domain upon binding of 
nanoparticles, or the interaction between cysteine residues in the heparin binding domain and the 
nanoparticles [Bhattacharya R. and Mukherjee P., 2008]. 
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Another important use of intracellular delivery of metallic nanoparticles is for bioimaging, where 
the main role is either as contrast agents or as autofluorescent reporters. As explained above, 
another very promising application is the enhancement of molecular fluorescence of various 
fluorophores by nanoparticles. Conventional contrast agents suffer from photobleaching, having 
broad overlapping emission spectra making multicolour imaging troublesome, and 
excitation/emission spectra susceptible to environmental changes. On the other hand 
nanoparticles demonstrate increased in vivo and in vitro stability, resistance to photobleaching, 
high quantum yield and high absorbance, resistance to metabolic breakdown, non-toxicity, and 
adequate dispersibility in the biological environment [Sharma P., et al., 2006]. The most 
widespread employed nanoparticles for imaging are dye-doped silicon nanoparticles, quantum 
dots, and gold nanoparticles. In the first two cases the basis of imaging relies on the dye or the 
fluorescence of the quantum dot particles, respectively. As explained above, autofluorescent gold 
nanoparticles are now readily available for direct use as fluorescent tags. However, still the 
majority of the reports in the literature depend on using gold nanoparticles as contrast agents. 
 
1.5.2 Methods of delivery 
It is now clear that metallic nanoparticles among with other products of nanotechnology offer a 
wide range of possibilities for biological sciences, ranging from detection, sensing, and imaging 
to therapeutics. One critical step in such processes is the intracellular delivery of nanoparticles, 
and there are already several methods available for that purpose. The most straightforward and 
the simplest method is perhaps the use of “naked” nanoparticles, i.e. nanoparticles not coupled to 
any type of carrier. Nanoparticles have been used as carriers of nucleic acids and proteins into the 
cells for some time already [Sokolova V. and Epple M., 2008]. This ability of nanoparticles arise 
from their size which is small enough to penetrate the plasma membrane, their biostability, non-
toxicity, and their ability to bind to various types of molecules as cargo. The other methods of 
delivery include usage of liposomes, dendrimers, or fullerenes. Every method has its advantages 
and disadvantages. Since in this study dendrimers were employed for the intracellular delivery, a 
more detailed description will be presented here. 
 
Dendrimers represent a class of polymers characterised by their well-defined structure, with a 
high degree of molecular uniformity and low polydispersity, which is a measure of the 
distribution of molecular weights in a given polymer. Dendrimers – consisting of a central core 
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branched cell, interior branch cells possessing surface groups – are synthesized either by a 
divergent (radial synthesis from a central core through stepwise repetitive reactions) or a 
convergent (construction of branched subunits followed by their attachment to a multifunctional 
core) approach [Tomalia D.A., et al., 1985; Hawker C. and Fréchet J.M.J., 1990]. Both 
approaches lead to a dendritic architecture with properties amenable to modifications of shape, 
size, polarity, surface properties and internal structure. Due to such versatility dendrimers have 
attracted great interest as potential drug delivery systems in biomedical applications, and in metal 
complexation, magnetic resonance imaging, host-guest chemistry, and glycomics [Wolinsky J.B. 
and Grinstaff M.W., 2008]. 
 
The ability of dendrimers to enter cells is one of their key properties, which make them good 
candidates in the above mentioned potential applications. A detailed understanding of the 
mechanisms by which dendrimers are taken up by, and transported within cells is required in 
order to optimise dendrimer-based delivery systems [Najlah M. and D’Emanuele A., 2006]. Such 
mechanisms depend strongly on the surface properties of the dendrimers in question. Kannan and 
co-workers studied the dynamics of cellular entry of four different dendrimers into cultured 
human lung epithelial carcinoma cells: one with amine groups, one with hydroxyl groups, and 
one covered with PEG, and a hyperbranched polymer (polyol). The species carrying amine 
surface groups entered the cells faster than the other ones. The rapid entry of the amine 
containing dendrimers suggests that an electrostatic interaction between the positively charged 
amino group and the negatively charged epithelial cells leading to fluid phase pinocytosis is the 
underlying process [Kannan S., et al., 2004; Kohle P., et al., 2004]. 
 
Depending on the intended use, the cargo has to be carried within the dendrimers or on their outer 
surface. Cargo complexing with surface of the dendrimer might not only limit the internalisation 
process, but also is subject to easy detachment e.g. by enzymes, pH, temperature, ionic strength 
for in vivo as well as in vivo experiments. Therefore, it might be reasonable to embed the cargo 
within the interior of the dendrimer, when it is important not to lose the cargo in a complex buffer 
system, as for instance in the body. The following figure (Fig. 11) illustrates the available ways 
of cargo complexation with the nanoparticles, where the cargo in this particular example is metal. 
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Figure 11. Dendrimers can have metal containing end groups (A), metal containing cores (B) or metal 
containing branches (C). Dendrimers can also encapsulate metal nanoparticles (D) [figure taken from 
Ravoo B.J. 2008]. 
 
In this study, oligosaccharide-modified poly(propyleneimine) dendrimers (PPI) were employed. 
PPI dendrimers were synthesized via reductive amination for the introduction of di- or 
trisaccharide units as surface groups with minimal synthetic steps [Baigude H., et al., 2004]. This 
reaction results in the simultaneous coupling of two oligosaccharide units for one amino surface 
group, which in turn results in not only a higher rigidity of the molecular structure but also an 
improved biocompatibility conferred by the oligosaccharide groups [Appelhans D., et al., 2007]. 
The synthesis is shown in fig. 12. 
 
 
Figure 12. Synthesis of first and second generation PPI dendrimers (1–4) with oligosaccharide units. The 
values in parentheses show the yield of the synthesis process [figure taken from Appelhans D., et al., 
2007]. 
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In biological research, metal complexed dendrimers are extensively used as sensors, catalysts, 
contrast agents in magnetic resonance imaging (MRI), carriers of therapeutic nanoparticles, and 
many more applications which require a strict control over the geometry of the metallic 
nanoparticle and the carrier system [Ravoo B.J. 2008]. Furthermore, dendrimers are attractive 
protective agents for metallic nanoparticles, especially gold ones, because: (i) the dendrimer 
templates themselves are of fairly uniform composition and structure, and therefore they yield 
well-defined nanoparticle replicas; (ii) the nanoparticles are stabilized by encapsulation within 
the dendrimer, and therefore they do not agglomerate; (iii) the dendrimer branches can be used as 
selective gates to control access of small molecules (substrates) to the encapsulated nanoparticles; 
(iv) the gold nanoparticles protected by dendrimer own very small size, typical 1–5 nm, which 
will find application in catalysis due to their high activity and surface-to-volume ratio and as 
autofluorescent gold nanoparticles. In their paper Appelhans and co-workers describe the 
complexation of the dendrimers with copper. In our study we used them for carrying 
autofluorescent gold nanodots into cultured human cells. 
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2. Materials and Methods  
 
2.1 Equipment  
 
2.1.1 Consumables and equipment  
Consumable/equipment Type Brand 
6- and 96-well plates  TPP or Nunclon 
Amber coloured reaction 
tubes 
1.5 ml Eppendorf 
Centrifuge tubes 5 ml, 50 ml, 500 ml Beckman 
Coverslips 22 x 22 or 24 x 24 Menzel Gläser 
Dialysis membranes 0.025 µm, VS type Millipore or Roth 
Erlenmeyer flasks 50 ml, 100 ml, 250 ml,  
500 ml, 1L, 2L, 3L, 5L 
Schott or Simax 
Gel blotting paper GB-002, GB-003 Schleicher and Schuell 
Glass slides  Menzel Gläser 
Immobilon™-P Polyvinylidene difluoride 
(PVDF) Membranes 
Millipore 
Neubauer cell counting 
chamber 
2 x 0.1 mm3 Brand 
Petri dishes  Greiner 
Pipette tips 1000 µl, 200 µl, 10 µl TPP 
Pipettes P1000, P200, P20, P10 Gilson 
Poly-L-lysine collated glass 
slides 
 Roth 
Reaction tubes 0.5 ml, 1.5 ml, 2.0 ml Eppendorf or Plastibrand 
Reaction tubes 15 ml, 50 ml Greiner or TPP 
Spectrophotometer cuvettes special optical glass or quartz 
3500 µl, 1400 µl 
Hellma 
T75 cell cluture flasks  TPP 
X-ray films  GE Healthcare or Kodak 
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2.1.2 Devices  
Device Model Brand 
Centrifuge Biofuge pico Heraeus 
Centrifuge Biofuge fresco Heraeus 
Centrifuge 5417R Eppendorf 
Centrifuge 3K30 Sigma 
Centrifuge Avanti™ J25 Beckman 
Thermo cycler Cyclone 96 PeqLab 
Light microscope H 600 Wilo-Prax Archo HUND WETZLAR 
Fluorescence microscope 
Filter sets 
Camera 
Axiovert200M 
09, 10, 15 
Cascade 512B 
Zeiss 
Zeiss 
Roper Scientific 
Scanning electron 
microscope 
Leo982 digital Zeiss 
Scanning Probe Microscope  
connected with a  
fluorescence microscope 
BioScopeTM 
 
axiovert 100M 
Digital Instruments Inc. 
 
Zeiss 
Laser scanning microscope 
mounted on a 
wide field microscope 
LSM 510 meta 
 
Axioscope 2 mot FS 
Zeiss 
FPLC System 500 series Pharmacia Biotech 
Water bath 1083 GFL 
Incubator  Binder or Heraeus 
UV/Vis spectrophotometer Ultrospec 3000 Pharmacia Biotech 
UV/Vis spectrophotometer Cary 50 Varian 
Microplate reader Infinite® 200 Tecan 
Fluorescence spectrometer FluoroMax-3 HORIBA Jobin Yvon GmbH 
Plasma Etcher Plasma-Prep™ II Spi Supplies 
Concentrator  5301 Eppendorf 
Sonicator  Sonopuls Bandelin 
Electroporation system Gene Pulser
® 
II Bio-Rad 
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Heating block  Eppendorf or Kleinfeld 
Vortexer  IKA-Works Inc. 
Blotter  PeqLab 
Power supplies  Bio-Rad or Pharmacia Biotech 
DNA/Protein gel chambers  PeqLab/Hoefer 
Gel-Doc system  MWG-Biotech 
  
2.2 Reagents  
 
2.2.1 Chemicals and reagents  
Chemical/Reagent Supplier 
3-Aminopropyltriethoxysilane (APTES) Pierce 
3-(Glycidyloxypropyl)trimethoxysilane 
(GOPTES) 
Sigma 
4-(2-aminoethyl)-benzenesulfonyl fluoride 
(AEBSF)  
AppliChem   
4-(2-hydroxyethyl)-1-piperazineethanesulfonic 
acid (HEPES) buffer 
Serva  
Acetic acid  Roth  
Acetone Roth 
Acrylamide/Bisacrylamide  Roth  
AcTEV buffer (20X) Invitrogen 
Agar  Roth  
Agarose  BioZym  
Ammonium (NH3) Roth 
Ammoniumperoxisulphate (APS) Merck  
Ampicillin  Roth  
BenchMark
™ 
Prestained Protein Ladder  Invitrogen   
Biotin  Merck  
Bromphenol blue  Serva  
Bovine Serum Albumin (BSA)  Serva  
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Calcium chloride (CaCl
2
)  Merck   
Casein from bovine milk Sigma 
Cetyl trimethylammonium bromide (CTAB) Sigma 
Chloramphenicol  Roth   
Coomassie
® 
Brilliant blue G250  Roth 
Dithiobis(sulfosuccinimidyl propionate) 
(DTSSP) 
Pierce 
Dithiothreitol  (DTT) 0.1M Invitrogen 
DMEM PAA 
dNTP’s  Invitrogen  
DTT Roth  
Ethanol  Roth  
Ethidiumbromide  Roth 
Ethylendiamine-tetraacetic acid (EDTA)  Roth  
Foetal Bovine Serum (FBS) PAA 
Formaldehyde Roth 
Fuming Nitric Acid (HNO3) Roth 
Glutamine PAA 
Glutathione Sepharose™ 4B GE Healthcare Life Sciences 
Glycerol  Roth  
Glycine  Roth  
Guanidinium hydrochloride (GuaHCl) Roth 
Herring sperm DNA  Invitrogen  
HPLC-grade water  Roth  
Hydrochloric acid (HCl)  Roth  
Hydrogen peroxide (H2O2) Roth  
Imidazol  Roth 
Isopropanol  Roth  
Isopropyl β-D-1-thiogalactopyranoside 
(IPTG) 
Roth 
Ligation Buffer (2X) Promega 
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Magnesium Chloride (MgCl2) 50 mM Invitek 
Methanol  Roth  
Mg++ free PCR buffer (10X) Invitek 
N,N,N’,N’-Tetramethylethylenediamine 
(TEMED)  
Roth  
Phosphate buffered saline (PBS) PAA 
Peptone/Tryptone  Roth  
Polyethylene glycol (PEG) Roth 
Polyvinylpyrrolidone  
average mol weight 40,000 Da (PVP40) 
Sigma 
Ponceau S  Roth  
Potassium chloride (KCl)  Merck  
Potassium dihydrogenphosphate (KH
2
PO
4
)  Merck 
Potassium hydroxide (KOH)  Roth  
Protease inhibitors Roche  
Restriction endonuclease buffers Invitrogen or Fermentas 
Skimmed milk powder  Lasana  
Sodium carbonate (Na
2
CO
3
)  Sigma  
Sodium chloride (NaCl) Roth  
Sodium dodecyl sulphate (SDS) Merck  
Sodium hydroxide (NaOH)  Roth  
ß-mercaptoethanol  Sigma or Roth  
Tris base  Roth or Merck  
Triton X-100  Roche or Roth  
Trypsin PAA 
Tween 20  Roth  
Yeast extract  Roth  
λ phage DNA EcoRI/HindIII cut Fermentas 
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2.2.2 Kit systems  
Kit Brand 
D
C 
Protein Assay  Bio-Rad  
ECL-Plus Kit™  GE Healthcare Life Sciences   
Jetquick PCR Purification Spin Kit  Genomed  
Nucleospin
® 
Extract Kit  Macherey-Nagel  
Nucleospin
® 
Plasmid Quick Pure Kit  Macherey-Nagel  
Wizard
® 
SV Gel and PCR Clean-Up Kit  Promega  
 
2.2.3 Enzymes and proteins 
Enzyme/Protein Supplier 
AcTEV protease  Invitrogen 
HA-eGFP and HA-CFP kindly provided by Denise Walther, IfG 
CombiZyme polymerase  Invitek  
Lysozyme Sigma-Aldrich 
rPhiYFP Evrogen 
Restriction enzymes  Invitrogen or MBI Fermentas  
T4 DNA ligase  Promega  
Trypsin EDTA (1:250) 1X PAA 
 
2.2.4 Metallic Nanoparticles 
Gold nanoparticles (60 nm diameter)    British Biocell International 
Gold nanoparticles and gold-silver alloyed nanoparticles (60 nm diameter; alloy NPs with a 23% 
Ag and 77% Au composition), synthesized by citrate reduction modified from Frins G. (1973) 
and according to El-Sayed (1999), respectively, were kindly provided by Mathias Lakatos 
(Institute of Materials Science, University of Technology Dresden). 
Gold nanoparticles (2 nm diameter) synthesized by sodium borohydrate reduction [Zheng J., et 
al., 2004] and embedded in polymeric dendrimers (Stp1831) [Appelhans D., et al., 2007] kindly 
provided by Mathias Lakatos and Dr. Dietmar Appelhans (Leibniz-Institut für Polymerforschung 
Dresden e. V). 
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2.2.5 Antibodies  
2.2.5.1 For Western blot analysis  
The antibodies were diluted as indicated in TBS-T buffer containing 5% (w/v) skimmed milk 
powder. 
Primary antibodies:  
Mouse-anti-GFP      Roche (1:5000)  
Goat-anti-GST     Roche (1:5000)  
Secondary antibodies:  
Sheep-anti-mouse IgG-HRP-coupled   Amersham Biosciences (1:5000)  
Donkey-anti-goat IgG-HRP-coupled   Amersham Biosciences (1:5000)  
 
2.2.5.2 For coupling to Gold Nanoparticles 
Mouse-anti-GFP     Roche 
Anti-HA      Roche 
Anti-HA high affinity    Roche 
Anti-rPhiYFP      Evrogen 
 
2.2.6 Media 
Media for E. coli     Recipe 
LB       1.0 % (w/v) Peptone/Tryptone  
       0.5 % (w/v) Yeast Extract 
       86 mM NaCl 
For solid plates additional    2.0 % (w/v) Agar 
pH adjusted to 7.4 by addition of NaOH 
For selection      100 mg/l Ampicllin 
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SOC       2.0 % (w/v) Peptone/Tryptone 
       0.5 % (w/v) Yeast Extraxt 
       10 mM NaCl 
       2.5 mM KCl 
       10 mM MgCl2 x 6H2O 
       10 mM MgSO4 x 7H2O 
       20 mM Glucose/Dextrose 
 
Medium for HeLa cells    Recipe 
DMEM cell culture medium    DMEM, high glucose (4.5 g/l) 
       10% ml FBS 
       2 mM L-Glutamine 
 
2.2.7 Buffers 
Buffer       Recipe 
TBE       90 mM Tris base 
       90 mM Boric acid 
       2.5 mM EDTA 
 
TBS (10X)      20 mM Tris-HCl (pH 7.4) 
       137 mM NaCl 
 
TBS-T       1X TBS 
       0.9 mM Tween 20 
 
PBS (pH 7.4)      137 mM NaCl 
       8 mM Na2HPO4 
       1.5 mM KH2PO4 
       2.7 mM KCl 
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DNA loading buffer (6X)    3.7 mM Bromophenol blue 
       9.7 M Glycerol 
 
E.coli lysis buffer     50 mM Tris-HCl (pH 7.8) 
       0.05 % (w/v) Lysozyme 
       1 mM AEBSF 
 
Potassium phosphate buffer 
Solution A:      KH2PO4 0.2M 
Solution B:      K2HPO4 0.2M 
Solution A and B mixed in the ratios provided in table 2 in appendix; volume then completed to 
200 ml 
 
Potassium acetate buffer 
Solution A:      Glacial acetic acid 0.2M 
Solution B:      KC2H3O2 0.2M 
Solution A and B mixed in the ratios provided in table 3 in appendix; volume then completed to 
100 ml 
 
2.2.7.1 Buffers and solutions for SDS-PAGE and Western blotting 
Buffer       Recipe 
Separating gel  (12%)     375 mM Tris-HCl (pH 8.8) 
1.7 M Acrylamide 
20.8 mM Bisacrylamide 
3.5 mM SDS 
4.4 mM APS 
8.6 mM TEMED 
 
 
 
 
 
Materials and Methods 
41 
Stacking gel (4%)     125 mM Tris-HCl (pH 6.8) 
0.6 M Acrylamide 
6.5 mM Bisacrylamide 
3.5 mM SDS 
4.4 mM APS 
8.6 mM TEMED 
 
Running buffer      25 mM Tris 
192 mM Glycin 
3.5 mM SDS 
 
6 x loading buffer      300 mM Tris-HCl (pH 6.8) 
3.3 M Glycerol 
350 mM SDS 
1.5 mM Bromphenol Blue 
600 mM DTT or 640 mM β-mercaptoethanol  
(freshly added) 
 
Coomassie blue stain      45 % (v/v) Methanol 
17 % (v/v) Acetic acid 
1.2 mM Coomassie brilliant blue G250 
 
Destaining solution      30 % (v/v) Methanol 
7 % (v/v) Acetic acid 
 
Transfer buffer      192 mM Glycine 
25 mM Tris 
5.0 % (v/v) Methanol 
3.5 mM SDS 
 
Ponceau S stain     6.6 mM Ponceau S 
1.0 % (v/v) Acetic acid 
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Blocking solution      TBS-T 
       5 % (w/v) skimmed milk powder 
 
2.3 Materials for genetic modification 
 
2.3.1 Primers 
Primers for the amplification of GST encoding sequence from pGEX-3 vector, addition of 
restriction endonuclease recognition sites, and introduction of the AcTEV protease target 
sequence were purschased from biomers. 
 
Forward primer (5’ to 3’): 
TAT ATA CAT ATG TCC CCT ATA CTA GGT TAT TGG AAA ATT AAG GGC C 
NdeI recognition site (underlined) 
 
Reverse primer (5’ to 3’): 
TAT ATA CTC GAG TCC CTG AAA ATA AAG ATT CTC TTT TGG AGG ATG GTC GC 
AcTEV protease target sequence (bold) and XhoI recognition site (underlined) 
 
2.3.2 Plasmids 
Plasmid      Source 
pGEX-3X (used as source for GST)   GE Healthcare Life Sciences 
pPhi-Yellow-B     Evrogen 
pET17b-eGFP (used as vector for the  
cloning of GST-eGFP fusion protein)   Blecha A., 2005 
pET17b-SbsCeGFP (used for over- 
expression of SbsC-eGFP)    Blecha A., 2005 
pET17b-GSTeGFP (cloned GST-eGFP 
overexpression vector)    this work (see Fig. 13) 
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PET17b-GSTeGFP
 
Figure 13. pET17b GST-eGFP expression vector (Ap: Ampicillin resistance gene). 
 
2.3.3 Strains 
Strain       Source 
E.coli Bl21 (DE3)     Novagen 
B, F-, ompT, gal, [dcm], [lon],  
hsdSB(rB-mB-), galλ(DE3) 
 
HeLa human cervical     kindly provided by Andreas Ettinger 
carcinoma cell line     (MPI-CBG, Dresden) 
 
2.4 Methods 
 
2.4.1 High yield production of eGFP 
2.4.1.1 Amplification of DNA by polymerase chain reaction 
The GST gene sequence was amplified from the commercially available pGEX-3X plasmid by 
standard PCR. The annealing temperature (TA) for PCR reaction was calculated according to the 
following formula [MWG-BIOTECH], where nGC represents the number of GC base pairs in the 
primer and nTotal is the total number of base pairs: 
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TA = 69.3ºC + 41(nGC/nTotal)ºC – (650/nTotal)ºC - 5ºC    (Eq. 8) 
 
The mix for the PCR consisted of: 1 ng/µl of the template, 0.2 mM of dNTP mix (containing 10 
mM of each dNTP), 1.5 pmol/µl of forward and reverse primers, 2.5 units of DNA polymerase, 
1X PCR buffer. The total volume was completed up to 100 µl with distilled water. The cycles 
used in the amplification are as follows: 1 cycle of initial denaturation at 95ºC for 5 minutes, 
followed by 20 cycles of denaturation (1 min, 94ºC), annealing (1 min, TA), elongation (2 min, 
72ºC), and final elongation at 72ºC for 5 min. The resulting fragments were cleaned up by using 
the kits listed in 2.2.2. 
 
2.4.1.2 Separation of DNA 
DNA fragments were separated by agarose gel (1% (w/v) agar dissolved in TBE buffer and 
containing 1 µg/ml of ethidium bromide for visualisation) electrophoresis in TBE buffer at 100V. 
Standard ladder was commercially available λ phage DNA digested with EcoRI and BamHI 
restriction endonucleases. After separation, the desired fragments were excised under UV light 
and cleaned up by using one of the kits listed in 2.2.2. 
 
2.4.1.3 Restriction enzyme digestion of DNA 
DNA was mixed with sterile bi-distilled water, the respective restriction enzyme buffer stock 
solution, and the restriction endonuclease with a final concentration of 1 unit per µg of DNA. The 
reaction mixture was incubated at 37ºC for 1 hour. The resulting fragments were cleaned up using 
one of the kits listed in 2.2.2. 
 
2.4.1.4 Ligation of DNA fragments 
Restriction endonuclease digested vector and insert DNA fragments were mixed in a 3:1 molar 
ratio in ligase buffer, and 2 units of T4 DNA ligase were added. The reaction mixture was 
incubated overnight at 4ºC. 
 
2.4.1.5 Preparation of electrocompetent E. coli cells 
An overnight grown E. coli BL21 (DE3) culture was diluted 1:100 in fresh LB medium and 
grown until an optical density at 600 nm of 0.5 to 0.8 was reached. Then the culture was chilled 
on ice for 15 min, followed by pelleting the cells by centrifugation at 4.000 x g for 15 min (4ºC); 
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and two subsequent washings with ice chilled sterile distilled water, and once with sterile 
glycerol (1.4 M). Finally cells were resuspended in 2 ml of 1.4 M of glycerol (aliquots stored at -
80ºC). 
 
2.4.1.6 Transformation of E. coli cells and isolation of plasmid DNA 
7 µl of ligation mixture was dialysed against sterile distilled water for 15 min, then mixed with 40 
µl of electrocompetent E. coli cells and transferred into a prechilled electroporation cuvette. 
Electroporation parameters were as follows: capacitance of 25 µF, resistance of 200 Ω, and 
voltage of 2.5 kV. After the pulse, the transformation mixture was diluted in 1 ml of SOC 
medium and transferred into an Eppendorf tube for incubation at 37ºC for 1 hour. The 
transformation mixture was pelleted at 6.000 x g at 4ºC or room temperature for 10 min and 
resuspended in LB medium. Transformants were selected on LB plates with ampicillin at 37ºC. 
 
Plasmid DNA from the transformed cells was obtained from overnight grown 2-3 ml cultures by 
using the appropriate kits listed in 2.2.2. 
 
2.4.1.7 Overexpression and extraction of GST-eGFP 
Cells containing the respective plasmids were inoculated in 2-3 ml of LB and were grown for 8 
hours to overnight, followed by diluting 1:1000 into 1L of LB. The cells were grown for 5-6 
hours, until an OD600 of 0.5-0.8 was reached; afterwards synthesis of the respective proteins for 6 
hours to overnight was induced by adding 50 mM of IPTG. 
 
For the extraction of the overexpressed proteins, the cells were spun down at 6.000 x g for 10 min 
at 4ºC, washed with cold 50 mM Tris-HCl buffer pH 7.4 two times, and resuspended in 20 ml of 
E. coli lysis buffer and incubated for 1 hour at 30ºC with gentle shaking for the cell wall 
components to be digested by lysozyme. Finally, the cells were incubated on ice for about 15 
minutes, followed by sonication for 6 cycles of 30 seconds with 70% - 80% of maximum power. 
Lysates were centrifuged at 12.000 x g for 30 min at 4ºC to separate the cytosolic fraction, 
containing the soluble GST-eGFP. GST-eGFP was purified by incubating the supernatant with 
Glutathione Sepharose™ 4B beads for 1 hour at 4ºC with gentle rotation, followed by 3 wash 
steps with PBS. The separation of GST-eGFP was carried out by incubating the beads with 50 
mM reduced glutathione in 50 mM Tris-HCl, pH 8.0 for 10 min at room temperature and finally 
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centrifuging at 500 x g to separate the beads from GST-eGFP. The protein concentrations before 
and after isolation were measured by using the BIO-RAD DC-Protein Assay. 
 
2.4.1.8 AcTEV protease digestion of GST-eGFP and isolation of eGFP 
The clear GST-eGFP solution was digested with AcTEV protease according to the protocol 
provided by the manufacturer: 
Fusion protein      20 µg 
20X TEV buffer      7.5 µl 
0.1 M DTT       1.5 µl 
AcTEV Protease, (10 units)     1.0 µl 
Water up to       150 µl 
The reaction mixture was incubated at various temperatures for various time periods to determine 
the most optimum conditions. The efficiency of digestion was determined by running the 
digested samples on SDS-PAGE, followed by western blotting. After the cleavage GST was 
removed by incubating the mix with Glutathione Sepharose™ 4B beads and centrifuging at 
500Xg to separate the GST bound beads from eGFP. eGFP was further purified from the AcTEV 
protease and other impurities via FPLC (using a Sephacryl™ S-300 column Pharmacia Biotech 
and degassed PBS or 50 mM Tris-HCl with varying pH as the running buffer). 
 
2.4.2 Overexpression of SbsC-eGFP 
2.4.2.1 Transformation 
The already available pET17b-SbsCeGFP plasmid was electroporated into electrocompetent 
E.coli BL21 (DE3) cells as explained in 2.3.1.5. 
 
2.4.2.2 Extraction of SbsC-eGFP 
Extraction of SbsC-eGFP form the cells were performed in a similar fashion to that of GST-
eGFP. The steps were the same until the first centrifugation after incubating on ice for 15 min. 
Due to the network structures formed by SbsC-eGFP already in the cell in the course of 
expression, the majority of the protein sediments to the pellet after centrifugation at 12000Xg for 
30 min at 4ºC. Therefore, after centrifugation, the pellet fraction was retained, which was then 
resuspended in 5M guanidium HCl with gentle shaking at room temperature for 20 – 30 min, 
leading to reversible denaturation and monomerisation of SbsC-eGFP. The monomers were 
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separated from cell debris via centrifugation at 16000Xg for 30 min at 4ºC. The recrystallisation 
of SbsC-eGFP monomers was carried out by dialysing the supernatant against sterile distilled 
water, PBS, or Tris-HCl buffer with varying pH values overnight at 4ºC. (Preparation of the 
dialysis membrane: desired size of the membrane was cut and boiled in 189 mM Na2CO3 solution 
containing 1 mM EDTA, pH 8.0 for 10 min, then rinsed with water, and finally boiled for another 
10 min in 1 mM EDTA, pH 8.0 and rinsed thoroughly with water. 
 
2.4.3 Overexpression of rPhiYFP 
Commercially available bacterial expression vector pPhi-Yellow-B was electroportaed into 
electrocompetent E.coli BL21 (DE3) cells as explained in 2.3.1.5. Transformants were selected 
by growing the cells on ampicillin (100 mg/ml) containing LB plates. A single colony was picked 
to start an overnight liquid culture, which was then diluted 1:1000 in a 1 L LB culture. The cells 
were grown until an OD600 of 0.5-0.8 is reached; afterwards the synthesis of the rPhiYFP was 
induced by adding 50 mM of IPTG and letting the cells grow overnight. The extraction of 
rPhiYFP was done in the same way as for eGFP until the sonication and following centrifugation 
step, as explained in 2.3.1.6. After centrifugation, cell debris was discarded, and the 
overexpressed rPhiYFP was separated from the rest of the supernatant by FPLC (using a 
Sephacryl™ S-300 column Pharmacia Biotech and degassed PBS or 50 mM Tris-HCl with 
varying pH as the running buffer). 
 
2.4.4 Preparation of samples for microscopy 
The inverse microscope Axiovert 200M (Zeiss) connected to a Cascade 512B camera (Roper 
Scientific) was employed for fluorescence microscopy. The filter sets (Zeiss) were as follows: 
Filter set: 09  excitation: 450-490 nm  emission:  515 nm 
  10    451-490 nm    515-565 nm 
  15    546 nm    590 nm 
 
Scanning microscopy was carried out by a digital SEM Leo 982 (Zeiss). The samples were 
analysed by changing magnification and acceleration voltage, typically 1-2 kV. The working 
distance was kept constant at 4 nm. 
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BioScope from Digital Instruments was used for analysis of surface structures in connection with 
fluorescence, the filter set for the fluorescence microscope was 09 (see above) and the AFM was 
used in the tapping mode. Unlike a conventional AFM, the samples were prepared on glass, for 
the possibility of fluorescence microscopy. 
 
2.4.4.1 Cleaning of glass slides and silicon wafers 
The substrate (glass slide or silicon wafer) was incubated in fuming nitric acid for 5 min, and 
then transferred into neutralisation solution (ddH2O:H2O2:NH3 in 5:1:1 volume ratio) for a 10 
min neutralisation reaction. The substrate was then rinsed thoroughly with double distilled water 
and heat dried in an oven at 105ºC for at least 1 hour. When no surface modification was 
required, eGFP or SbsC-eGFP and/or metallic nanoparticles were adsorbed onto cleaned glass 
slides (for fluorescence microscopy or BioScope analysis) or onto silicon wafers (for SEM), 
adsorption time varying from 5 minutes to 30 minutes in a humid chamber in order to minimize 
the evaporation of the medium, and eventually rinsing and drying with a nitrogen gun. 
 
2.4.4.2 Surface modifications 
For APTES modification, glass slides (or silicon wafers) were cleaned as explained in 2.3.4.1; 
then submerged into a solution containing 0.4 ml of 1 M APTES, 1 ml of ddH2O, and 19 ml of 
absolute EtOH for 2 min; followed by submerging into a beaker containing absolute EtOH for 20 
min before rinsing thoroughly with ddH2O and eventually heat drying at 105ºC for at least 
overnight. Adsorption onto APTES modified substrate was done the same way for unmodified 
substrate. 
 
For GOPTES modification, glass slides (or silicon wafers) were cleaned as explained in 2.3.4.1; 
then submerged into a solution of 0.2 mM of GOPTES in absolute EtOH for 5 min, followed by 
immersing in absolute EtOH for 20 min. Afterwards, the substrates were thoroughly rinsed with 
ddH2O and finally heat dryed at 105ºC for at least overnight. Adsorption onto GOPTES modified 
substrate was done the same way for unmodified substrate. 
 
For plasma modification, the substrate was incubated in the Plasma-Prep™ II plasma etcher 
under a pressure of 200 µatm under a radiowave frequency of 13.56 MHz for 30 min. Afterwards 
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the sample was adsorbed onto plasma treated substrate in the same manner as unmodified 
substrate. 
 
2.4.4.3 Maintenance, transfection, and preparation of HeLa cells for fluorescence microscopy 
HeLa cells were grown to at least 75% confluence in T75 cell culture flasks in DMEM cell 
culture medium. The medium was removed and the cells were rinsed 3 times with PBS preheated 
to 37ºC, followed by incubating with 1 ml of 1X Trypsin at 37ºC until at least 75% of the cells 
looked round and floated under the light microscope. 9 ml of DMEM culture medium was added 
and the resulting cell suspension was transferred into a 50 ml reaction tube and the cells were 
spun down at 500Xg. The pellet was resuspended in DMEM cell culture, and total cell counting 
from the medium was performed using a Neubauer cell counting chamber with a grid. For further 
cultivation, the volume containing 500000 to 1000000 cells was completed up to 10 ml with 
DMEM growth medium and seeded into a T75 flask. 
 
For transfection, prior to seeding 22x22 mm glass slides were sterilised by autoclaving, 
transferred into EtOH under sterile conditions, and finally dried and laid to the bottom of each 
well of a 6-well plate, still under sterile conditions. After trypsinization and counting, 100.000-
200.000 cells were seeded in each well (total volume of 2 ml) and were grown overnight (to 
roughly 70% to 80% confluence). Afterwards 20 µl from of dendrimers (10 mg/ml) or 
dendrimers with embedded autofluorescent gold nanoparticles were added, so that a final 
concentration of 0.1 mg/ml was achieved. The structures were allowed to transfect cells for 4 
hours, then the cells were rinsed thoroughly with PBS and finally fixed with 3.7% (v/v) 
formaldehyde. The glass slips with fixed cells were mounted onto glass slides and eventually 
analysed by confocal laser scanning microscopy (the excitation of autofluorescent nanoparticles 
was carried out at 750 nm by a fibre-coupled coherent mira 900 NIR-fs-laser and the fluorescein 
moiety of the dendrimer structures was excited at 488 nm with argon laser source). 
 
2.4.5 Production of gold nanoparticles on SbsC-eGFP 
For the production of gold nanoparticles the citrate tannin reduction [Oliver C., 1994] was used.  
10 µl of 1 µg/µl of SbsC-eGFP was adsorbed onto a glass slide and a silicon wafer, incubated 
overnight with 3 mM of HAuCl4 for the association of gold atoms with the protein to serve as 
growth nuclei for gold cluster growth. The reduction of Au salt, i.e. growth of gold clusters was 
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carried out in a solution containing: 46.7 mM Na-Citrate, 72.4 mM K2CO3, 58.8 mM Tannin, and 
3 mM HAuCl4 for 15 min to 1 hour (Note that all the incubations on glass or silicon substrates 
were carried out in a humidified Petri dish). After the reduction, the slides were rinsed, dried and 
observed with SEM and FM. 
 
2.4.6 Conjugation of proteins to metallic nanoparticles 
Two main approaches for the conjugation of proteins onto gold or gold/silver alloyed 
nanoparticles have been adopted: use of chemicals and electrostatic adsorption. 
 
2.4.6.1 Crosslinking of eGFP to Au nanoparticles in solution 
eGFP was isolated as outlined above in PBS buffer (by using PBS as the running buffer in 
FPLC). Gold nanoparticles (with 60 nm diameter) were incubated with 1.7 M DTSSP in PBS for 
30 min at room temperature with gentle shaking. 5 mg/ml of eGFP was added and incubated for 
another 30 min at room temperature with gentle shaking. The reaction was stopped by adding 1 
M Tris solution at pH 7.5. The conjugated nanoparticles were cleaned up from the crosslinker and 
unconjugated eGFP via centrifugation at 6.000 x g for 10 minutes and gentle resuspension in 
PBS. The efficiency of crosslinking was evaluated via UV/Vis spectroscopy. 
 
2.4.6.2 Adsorption of eGFP (and rPhiYFP) onto Au nanoparticles at various pH values 
eGFP was experimentally determined to have a pI value of 5.5 via isoelectric focusing followed 
by SDS-PAGE. The buffers of choice for generation of pH values near that value were potassium 
phosphate and potassium acetate buffers. Adsorption was carried out by incubating 5 mg/ml of 
eGFP with varying amounts of 60 nm-diameter gold nanoparticles at pH values varying around 
the pI value of eGFP, i.e. pH of 5.5, and at neutrality; followed by spinning down the 
nanoparticles at 6.000 x g for 10 min in order to separate them from unbound eGFP. The 
evaluation of the binding was confirmed by three methods. 
 
Firstly, 5 mg/ml of eGFP was incubated with varying amounts of Au nanoparticles at pH 5.5 and 
7.0 and spun down as explained above. Aliquots from the supernatants were run on 12% SDS-
PAGE, transferred onto a polyvinyl membrane and finally detected using antiGFP antibodies. 
The lack of eGFP bands indicated pelleting down of eGFP together with Au nanoparticles. 
Secondly, the same procedure was applied at the pH range as indicated above and the shift in the 
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LSPR peak upon adsorption of eGFP onto Au nanoparticles was measured by UV/Vis 
spectroscopy. Thirdly, the efficiency of adsorption was tested by fluorescence spectroscopy, 
assuming a stronger influence on fluorescence upon stronger binding. Samples were prepared the 
same way as for UV/Vis spectroscopy. Additionally, another set was prepared under the same 
conditions except with Au/Ag alloyed nanoparticles with a different LSPR peak, in order to be 
able to relate the change in fluorescence to Au nanoparticles. A second control was carried out by 
exchanging eGFP with rPhiYFP, i.e. the fluorescence signal intensity of rPhiYFP was compared 
to signal intensity of rPhiYFP incubated with Au nanoparticles at pH 7.0, rPhiYFP buffered at pH 
6.5 (its pI value), and rPhiYFP incubated with Au nanoparticles at pH 6.5. The sample 
preparation was the same as the above explained eGFP adsorption. 
 
2.4.6.3 Attachment of antiGFP antibodies onto Au nanoparticles 
Unlike the attachment of fluorophores onto Au nanoparticles, it is favoured to attach only a 
limited number of antibodies onto Au nanoparticles. For the determination of the most stable 
antibody to Au nanoparticle concentration salt test was applied. Dilution series from 0.4 mg/ml to 
4x10-5 mg/ml for the antiGFP antibodies was prepared in water and then mixed with Au 
nanoparticles (kept constant). After an incubation of 30 min at room temperature with constant 
gentle shaking, NaCl was added to the final concentration of 1 M. The stability of the conjugates 
was evaluated visibly by observing the coloration of the suspension, whereby blue is indicative of 
precipitation and red is indicative of stability. 
 
The adsorption of antiGFP antibodies onto Au nanoparticles was carried out at pH 8.0 
(theoretical pI value calculated by SwissProt). The unbound antibodies were removed by 
spinning the Au nanoparticles at 6.000 x g for 10 min and resuspending the pellet, followed by 
blocking with 1% (w/v) BSA, Casein, or PVP40. The efficiency of the binding was evaluated by 
UV/Vis spectroscopy in terms of shifts in the LSPR peak and by incubating the bioconjugated Au 
nanoparticles and unconjugated ones with SbsC-eGFP adsorbed onto silicon wafer, and 
observing the distribution of each group by SEM. The ability of the antiGFP antibodies 
conjugated to Au nanoparticles to bind to eGFP was evaluated by further LSPR shifts and 
changes in the fluorescence signal intensity of eGFP. 
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2.4.7 Au nanoparticles functionalised with antiHA antibodies and replacement of bound 
HA-eGFP by HA-CFP 
Solutions of varying concentrations of HA-eGFP and HA-CFP were prepared as follows: 
Solution [HA-eGFP] (mg/ml) [HA-CFP] (mg/ml) 
1 0.5 0 
2 1.0 0 
3 1.5 0 
4 0 0.5 
5 0 1.0 
6 0 1.5 
7 0.5 0.5 
8 1.0 1.0 
9 1.5 1.5 
Afterwards, aliquots from each solution were pipetted on a 96-well plate and the fluorescent 
signal from each well was measured (i) at 490 nm excitation/520 nm emission, and (ii) at 434 nm 
excitation/474 nm emission. 
 
60 nm-diameter nanoparticles were functionalised with standard antiHA antibodies and high 
affinity antiHA antibodies at concentrations of 4x10-5, 4x10-4, 4x10-3, 4x10-2, and 4x10-1 mg/ml, 
and then unoccupied Au nanoparticle surface was blocked with 1% (w/v) PVP40 (as explained in 
the previous section). The conjugates were incubated with 0.5 mg/ml of HA-eGFP at room 
temperature for 15 min with gentle shaking; the fluorescence signal at 520 nm was measured by 
exciting at 490 nm. This was followed by addition of 0.5 mg/ml HA-CFP and a further 
incubation at room temperature for 15 min with gentle shaking; and the fluorescence signal at 
520 nm was measured by exciting at 490 nm. 
 
2.4.8 Quantification of fluorescence signals of transfected HeLa cells 
HeLa cells were trypsinized. After counting, 15.000 cells (per well) in DMEM cell growth 
medium were seeded in the wells of a 96-well plate, while an equal number of wells were only 
filled with DMEM growth medium and were grown overnight. Firstly, into two wells (one 
containing cells and one without) dendrimers conjugated to autofluorescent nanoparticles were 
added to a final concentration of 0.1 mg/ml; into another two wells (one with cells, one without) 
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only dendrimers were added (0.1 mg/ml final concentration). After 8, 10, 11, and 12 hours, 4 new 
sets of wells were treated the same way, so that the plate contained: 
1. cells transfected with dendrimer-autofluorescent Au nanoparticles for 12, 4, 2, 1, and 0 hours 
2. cells transfected with dendrimers for the same time periods 
3. empty wells incubated with dendrimer-autofluorescent Au nanoparticles for the same time 
periods 
4. empty wells incubated with dendrimers for the same time periods 
5. untransfected cells as well as wells incubated with DMEM but not incubated with any of the 
structures. 
Wells were rinsed with PBS and the fluorescence signal from the autofluorescent Au 
nanoparticles from each well was measured by the plate reader with excitation at 270 nm and 
emission at 610 nm. 
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3 Results 
 
3.1 Formation of protein assemblies with SbsC-eGFP 
For the ease of microscopic visualization of the effect of near-field enhancement around metallic 
nanoparticles on eGFP, the intrinsic property of SbsC to form a well defined tube-like structure 
was exploited. The SbsC-eGFP fusion protein was adsorbed onto various substrates under 
different conditions in order to find the most suitable adsorption method which would produce a 
surface covered with SbsC-eGFP tubes. For the details of high yield production of SbsC-eGFP 
and the other fluorescent proteins, please refer to the appendix 
 
3.1.1 Adsorption of SbsC-eGFP and metallic nanoparticles onto unmodified glass and 
silicon 
It should be noted that glass surface and silicon surface mimic each other in terms of surface 
charge and behaviour at the same pH values; although that does not necessarily mean that their 
surface characteristics are identical [Simões L.C., et al., 2007]. The above mentioned similarity is 
simply due to the fact that both surfaces are silicon oxides. 
 
Another component in the scheme of observing the effect of metallic nanoparticles on eGFP is 
naturally the metallic nanoparticles. Therefore, the optimization of surface properties for the 
binding of SbsC-eGFP should also take the binding of nanoparticles onto the surface into 
consideration. The main characteristic of nanoparticles which determines the interaction with a 
substrate is their surface charge, which in turn is determined mainly by the protective surfactant 
[Hauck T.S., et al., 2008]. Both the commercially purchased gold nanoparticles and those 
synthesized in our group bear a net negative charge as shown by their migration towards the 
anode in agarose gel electrophoresis [Jiang X., 2006]. 
 
As explained in the methods part, guanidine hydrochloride prevents the SbsC-eGFP monomers 
from polymerizing, i.e. keeps them as monomers. The first approach was to dialyze the 
monomers to get rid of GuaHCl in order to allow them to polymerize in the dialysis tube, 
followed by adsorbing them onto glass slides for atomic force microscopy (Fig. 14). 
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Figure 14. AFM analysis of SbsC-eGFP tubes and gold nanoparticles adsorbed onto glass. SbsC-
eGFP tubes were adsorbed onto glass slides followed by incubation with gold nanoparticles of 60 nm 
diameter, and AFM images were taken (A and C). Height profiles were taken at two different points 
(indicated by green dashes in A andC): In a region that is devoid of nanoparticles (A and B), and in a 
region where SbsC-eGFP tube is interacting with a gold nanoparticle (C and D). 
 
SbsC-eGFP forms the expected tube structures that are randomly distributed on the surface. Yet a 
certain amount interacts with the nanoparticles. The height of the SbsC-eGFP tubes (8 nm on 
average) is in the expected range [Blecha A., 2005]. However, the height of the nanoparticles 
seems to be less than 60 nm. This is due to the spherical shape of the nanoparticles: the AFM tip 
does not measure the maximum height of the nanosphere due to random contact. The size of the 
nanoparticles was confirmed to be 60 nm by SEM. Therefore, the average AFM measurement of 
25 nm is accepted to be the internal error. 
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3.1.2 Surface modifications on glass and silicon 
In the pH range of PBS, glass has an overall negative charge. In order to see the effect of charge 
of surface on the behaviour of SbsC-eGFP, glass slides and silicon wafers were treated with 
different chemicals and processes, which mostly give an overall positive charge, then incubated 
with the SbsC-eGFP and/or nanoparticles and finally analyzed by microscopic methods. 
 
3.1.2.1 APTES treatment 
3-aminopropyltriethoxysilane is a chemical commonly used to promote adhesion between glass 
or other siliceous surfaces and organic or metallic materials with applications ranging from 
advanced composites to biomolecular lab-on-a-chip applications [Howarter J.A. and Youngblood 
J.P., 2006]. APTES acts by creating positively charged aminopropyl groups on the surface onto 
which anionic matter can adsorb. 
 
 
Figure 15. AFM image of SbsC-eGFP and gold nanoparticles adsorbed onto APTES functionalised 
glass. Patches formed by SbsC-eGFP with (A) and without gold nanoparticles (B). 
 
Interaction of SbsC-eGFP with APTES treated glass seems to be different from that with 
untreated glass, as clearly evidenced by the formation of sheet like structures rather than the 
expected tubes. The patches and spots were determined to be SbsC-eGFP and nanoparticles 
respectively by height analysis (data not shown). 
 
3.1.2.2 GOPTES treatment 
(3-Glycidyloxypropyl)trimethoxysilane is another silane used as an alternative to APTES. The 
mechanism of action of GOPTES is the production of epoxy-silane groups on the surface of 
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choice. The main advantage of GOPTES over APTES is the fact that epoxysilane groups are 
more reactive as compared to aminopropyl groups [Tsukruk V.V., et al., 2002]. 
 
C
 
Figure 16. eGFP adsorbed on GOPTES treated glass. eGFP molecules attached to the epoxysilane 
groups (A), uncovered glass (B), and eGFP aggregates (C) (100x magnification) 
 
As can be seen in Fig. 16, eGFP covers an epoxysilane functionalised glass quite uniformly, even 
though some aggregates can be observed. Covering is obvious when compared to the bottom left 
corner (uncovered). The adsorption behaviour of SbsC-eGFP on GOPTES treated glass was also 
analysed (please refer to fig 17). The typical tube-like structures, which provide a means for 
identification under the microscope, were formed on GOPTES treated glass.  
 
3.1.2.3 Plasma treatment and poly-L-lysine coated glass 
Gas plasma treatment is extensively used for chemical modification of a polymer surface. For 
example, nonpolymerizing gas plasma treatment may create reactive sites on the surface of 
polymers Wang D.Y., et al., 2007]. It has been previously shown that during the course of 
oxygen plasma treatment the number of oxygen bonded to silicon gradually increases [Olander 
B., et al., 2004], which increases the wettability, i.e. the hydrophilicity of the surface. 
 
The oxygen plasma treatment did not confer any advantage over regular silicon wafer. However, 
on the other hand the adsorption of the nanoparticles seemed to be reduced. This is most probably 
due to the charge repulsion between negatively charged gold nanoparticles and the hydroxyl 
groups introduced by the oxygen treatment. 
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In addition to the above mentioned chemical surface modification methods, the adsorption 
behaviour of SbsC-eGFP and nanoparticles were tested on poly-L-lysine glass. Like aminopropyl 
and epoxysilane groups, lysine is positively charged due to its ε-amino group; so that it confers 
an overall positive charge to the surface. However, the main difference between lysine and the 
two other methods is that lysine is an amino acid. Therefore the main motivation to test it was to 
observe the efficiency of adsorption of SbsC-eGFP onto biological matter rather than a 
chemically modified surface. 
 
Poly-L-lysine glass slides proved to be too rough for AFM analysis, no structure was visible on 
the slides (data not shown). Therefore, the usage of this type of slides was abandoned. 
 
3.2 Effect of nanoparticles on eGFP fluorescence on a microscope slide 
The aim of this study is to investigate the effect of nanoparticles on fluorescent proteins, i.e. to 
determine whether fluorescence is reduced or enhanced or unaffected. To this end, the most 
suitable surface modification was selected, which in our case turned out to be epoxysilanization 
by GOPTES treatment. In a sequential approach SbsC-eGFP was first deposited on epoxysilane 
functionalized glass, followed by deposition of gold nanoparticles. The following image (Fig. 17) 
shows the fluorescence and AFM images of such structures. 
 
 
Figure 17. Effect of nanoparticles on the fluorescence of eGFP. (A) Fluorescence image of SbsC-eGFP 
and gold nanoparticles (60 nm) adsorbed onto GOPTES treated glass. (Magnification 100 x; for details see 
text. (B) AFM image of the area indicated by the red rectangle in (A). (C) Zoomed-in fluorescence 
microscopy image of the rectangled area of (A). Height profile is in agreement with Fig. 14 (data not 
shown). Yellow arrows indicate the positions of gold nanoparticles. 
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Firstly, it should be noted once again that SbsC-eGFP retains the characteristic tube-like 
appearance on an epoxysilane functionalized glass. Along the rod in the red rectangle of Fig. 17 
A, fluorescence is discontinuous. When this SbsC-eGFP tube was analysed by AFM (B), all the 
structures are doubled due to a phenomenon called double tip (if the tip is broken, or 
contaminated, one can often get a "double tip" effect, where both the tip and the contamination 
are scanning the surface, so that the structures scanned have twins). In spite of this, three 
nanoparticles could clearly be observed and were identified by height measurement. In C, the 
same area is presented with a zoom. Upon comparing the AFM image with the fluorescence 
pictures, it becomes clear that the discontinuity of fluorescence is limited to the parts of SbsC-
eGFP that interact with the gold nanoparticles. 
 
3.3 Formation of nanoparticles on SbsC-eGFP 
One of the well established easy, rapid, and cheap methods of producing gold nanoparticles is 
reducing gold complexes with the help of a reducing agent such as citric acid [Philip D., 2007]. It 
has been suggested that a very efficient method of conjugating nanoparticles to proteins is 
synthesizing nanoparticles via chemical reduction in aqueous solutions containing globular 
proteins, where the unreduced gold is first incubated with the globular proteins and then reduced. 
This method has been claimed to eliminate the necessity to use a linker, passivation of 
nanoparticles by protective agents, and to prevent nanoparticle aggregation [Burt J.L., et al., 
2004]. In our approach, SbsC-eGFP tubes were first adsorbed onto glass slides and silicon 
wafers, onto which then gold nanoparticles were deposited by chemical reduction of the gold 
complexes via citric acid. Formation and distribution of gold nanoparticles were observed by 
scanning electron microscopy. The effect of gold nanoparticles on the fluorescence behaviour of 
eGFP was analysed by fluorescence microscopy. 
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Figure 18. SEM image of SbsC-eGFP tubes bearing gold nanoparticles. Gold nanoparticles were 
synthesized on the SbsC-eGFP tubes which had been adsorbed on a silicon wafer prior to the gold 
nanoparticle synthesis. 
 
First implication to be taken from the SEM image (Fig. 18) is that formation of the nanoparticles 
on the SbsC-eGFP by reduction is successful, resulting in the formation of uniformly sized 
nanoparticles on the SbsC-eGFP tubes. However, the technique seems to deform the tubes 
because the protein in the image no longer demonstrates the typical tube-like organization.  
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Figure 19. Fluorescence images and intensity profiles of SbsC-eGFP bearing gold nanoparticles. 
SbsC-eGFP adsorbed onto glass (A); gold nanoparticles were formed on the SbsC-eGFP as explained in 
the text and the resulting conjugates were adsorbed onto glass (B). The fluorescence signal intensity 
profiles of SbsC-eGFP (C) and of SbsC-eGFP-nanoparticle conjugates (D) (100 x magnification) 
 
From the comparison of the fluorescence signals and intensity profiles (A and C to B and D, 
respectively), it seems that eGFP fluorescence signal is significantly reduced. This can be due to 
denaturation of eGFP or quenching of the signal. 
 
3.4 Quantification of the effect of nanoparticles on eGFP in solution 
Although the fluorescence and scanning electron microscopy images prove to be valuable tools 
not only for analysing the interaction of SbsC-eGFP with metallic nanoparticles, but also for the 
determining, how nanoparticles affect the fluorescence signal of eGFP, the images obtained due 
to changing parameters are difficult to compare. Moreover, for the images obtained by 
microscopy specimens were used, which were adsorbed onto various substrates, and this does not 
necessarily simulate the situation in a solution. 
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In the following chapters the conjugation and interaction of gold or silver nanoparticles or gold-
silver alloy nanoparticles to eGFP or yellow fluorescent protein (rPhiYFP) by different methods 
and the effect they exert on fluorescence is described without the additional influence of a 
substrate. 
 
3.4.1 Effect of pH on binding efficiency and change in fluorescence signal of fluorescent 
proteins onto nanoparticles  
As explained before the nanoparticles utilised in this work bear a net negative charge. Therefore 
one of the most straightforward methods for conjugating proteins onto them is to cause an 
electrostatic attraction. Another advantage of such an electrostatic interaction is the stability of 
the binding [Brewer S.H., et al., 2005; Tkachenko A. et al., 2005]. 
 
Firstly, the optimum ratio between nanoparticles and eGFP was estimated by testing the stability 
of the conjugates containing different nanoparticle to eGFP ratios in a solution with a high salt 
concentration. Nanoparticles are negatively charged and the cations in the salt solution cause the 
aggregation of the nanoparticles. However, if they are stabilized by proteins, polymers etc., the 
salt bridges are not formed and the nanoparticles are stable in the saline solution [Rouhana L.L., 
et al., 2007]. The destabilization of nanoparticles is observed by the colour of the suspension 
turning to blue. However, the results of this test are not definitive, just gives an idea about the 
optimum ratio between the nanoparticle concentration and adsorbed material concentration, 
because it is assumed that nanoparticle-protein conjugates which are stable at very high salt 
concentration are also stable at lower concentrations. 
 
First proof to the successful binding of eGFP onto nanoparticles comes from Western blots. The 
same molar concentration of protein was incubated with equal amount of gold nanoparticles at 
neutral pH and pH 5.5. Afterwards the nanoparticles were spun down and aliquots from the 
supernatants were run on 12% SDS-PA gel, followed by Western blot transfer (Fig. 20). 
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Figure 20. eGFP in the supernatant after adsorption onto gold nanoparticles. eGFP was adsorbed 
onto gold nanoparticles (60 nm diameter) at neutral pH (lanes 1-6) and pH 5.5 (lanes 7-12), and then the 
nanoparticles were spun down and the supernatant fractions were checked for eGFP content. Controls, i.e. 
eGFP without nanoparticles are the lanes 1 and 7. Lanes 2-6 and 8-12 represent an increasing nanoparticle 
to eGFP ratio, where NP amount was kept constant. 
 
The supernatants from the samples incubated at neutral pH showed strong protein bands, whereas 
no protein band was visible in any of the aliquots taken from the samples incubated at the pI 
value of eGFP. This clearly hints to a far more effective adsorption at the pI value of the protein, 
since the protein precipitates with the nanoparticles in the pellet fraction upon centrifuging at a 
speed not high enough to precipitate unconjugated eGFP, i.e. 6.000 x g. 
 
The efficiency of the binding was then evaluated then by UV/Vis spectroscopy. Due to the 
presence of localised surface plasmons the metallic nanoparticles possess a characteristic peak in 
the UV/Vis absorption spectrum. The wavelength of the peak is a function of the size, shape, and 
composition of the nanoparticles, as well as the dielectric constant of the surrounding medium 
[Lue J.-T., 2001]. The binding of a protein, polymer, etc. on the surface of a nanoparticle changes 
the dielectric medium of the environment and hence induces a shift in the position of the plasmon 
peak. Therefore, when using nanoparticles with the same size, shape, and composition, it is 
possible to measure the efficiency of binding by measuring the shift in the plasmon peak. 
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Figure 21. Shift in the plasmon peak of AuNPs upon eGFP adsorption at different pH values. eGFP 
was adsorbed onto 60 nm diameter gold nanoparticles at different pH values and their absorption spectra 
were measured. The size of the shift of the LSPR peak relative to unconjugated NPs is presented on the 
graph. 
 
The graph (Fig. 21) illustrates that the shift in the plasmon peak is greater when eGFP is adsorbed 
onto nanoparticles at a pH value close to its pI value. 
 
The third method for testing of the binding of nanoparticles to fluorescent proteins was to 
measure the change in their fluorescence signal upon binding to nanoparticles; inspired from 
existing literature and previous results. As explained above, binding of nanoparticles to SbsC-
eGFP tubes diminish the fluorescence of the tubes at the contact points between nanoparticle and 
fluorescent protein. By taking that into account, it was expected to see a stronger reduction in the 
fluorescence signal of the fluorescent proteins upon a more efficient binding, i.e. a higher ratio of 
bound protein. 
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Figure 22. Dependence of eGFP fluorescence signal on the nanoparticles and pH. Same concentration 
of eGFP was adsorbed onto two types of nanoparticles: gold nanoparticles, and gold and silver alloyed 
nanoparticles, both with 60 nm diameter. Green columns: eGFP fluorescence signal at different pH values; 
yellow columns: eGFP signal upon adsorption to gold nanoparticles at various pH values; teal columns: 
eGFP fluorescence signal upon adsorption to alloyed nanoparticles at the same pH values (emission at 520 
nm and excitation at 490 nm). 
 
As can be observed from the graphs (Fig. 22) eGFP fluorescence signals are reduced when 
conjugated to gold nanoparticles, which have a plasmon peak around 520 nm. The extent of 
fluorescence reduction is more pronounced, when binding is carried out at the pI value of eGFP. 
On the other hand silver-gold alloyed nanoparticles, which have plasmon peak at 490 nm, seem 
not to strongly affect eGFP fluorescence. This is in accordance with the UV/Vis spectroscopy and 
Western blot data. The first conclusion that can be drawn from these results is that the most 
effective binding of eGFP onto nanoparticles takes place at its pI value. However, the main focus 
is the effect of the nanoparticles on fluorescence. What remains as a question is the reason for the 
observed reduction in the fluorescence signal. One possible explanation can be the denaturation 
of eGFP by the near field enhancement around the nanoparticles. Yet another and perhaps more 
likely explanation is the interaction of metallic nanoparticles with the fluorescence signal without 
denaturing the proteins. It is well documented in literature that metallic nanoparticles interact 
with fluorophores either by quenching or by enhancing their fluorescence signals [Kühn S., et al., 
0,00E+00
2,00E+06
4,00E+06
6,00E+06
8,00E+06
1,00E+07
1,20E+07
1,40E+07
pH
Fl
uo
 in
te
ns
ity
eGFP ex:490nm
eGFP + AuNPs ex:490nm
eGFP + AlloyNPs ex:490nm
eGFP ex:490nm 6,80E+06 9,70E+06 1,00E+07 5,80E+06 1,10E+07 1,00E+07
eGFP + AuNPs ex:490nm 4,70E+06 5,60E+06 6,00E+06 3,40E+06 7,70E+06 8,90E+06
eGFP + AlloyNPs ex:490nm 5,80E+06 9,70E+06 1,00E+07 5,40E+06 1,00E+07 1,10E+07
pH 5,0 pH 5,2 pH 5,4 pH 5,5 pH 5,6 pH 7,0
Results 
66 
2006; Anger P., et al., 2006]. Same type of experiments were done by adsorbing rPhiYFP onto 
gold nanoparticles (Fig. 23) 
 
 
Figure 23. pH-dependence of rPhiYFP fluorescence. rPhiYFP was adsorbed onto 60 nm diameter 
nanoparticles at neutral pH and at pH 6.5 (i.e. the pI value of rPhiYFP). The graph shows the comparison 
of the fluorescence signal (emission at 535 nm and excitation at 525 nm) between non-adsorbed rPhiYFP 
at pH 7.0 (first column), rPhiYFP adsorbed onto nanoparticles at pH 7.0 (second), non-adsorbed rPhiYFP 
at pH 6.5 (third), and rPhiYFP adsorbed onto nanoparticles at pH 6.5 (fourth). 
 
As in the case of eGFP, the adsorption of rPhiYFP onto nanoparticles seems to be most effective 
at the pI value. However, contrary to gold nanoparticles the fluorescence of rPhiYFP seems not to 
be reduced by the nanoparticles, rather an enhancement in fluorescence is observed. By tuning 
the plasmon peak of nanoparticles, which is possible by using gold-silver alloyed nanoparticles 
with different gold to silver ratio and hence different plasmon peaks, it is possible to reduce the 
extent of fluorescence reduction of the eGFP fluorescence signal. Taking into account that 
alloyed nanoparticles with a LSPR peak at 490 nm either do not quench eGFP fluorescence or do 
not quench as strong as gold nanoparticles with LSPR peak at 520, it seems likely that the effect 
of nanoparticles on the fluorescent proteins is not to due to denaturation, but either to enhance or 
to quench their signals, depending on the nature of the fluorophore and of the nanoparticles of 
choice. 
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3.4.2 Cross-linking of proteins onto nanoparticles 
In order to compare the efficiency of cross-linking proteins onto nanoparticles with the efficiency 
of adsorbing them at their pI values, eGFP was cross-linked to gold nanoparticles by DTSSP; and 
the binding was monitored by UV/Vis and fluorescence spectroscopy (Fig. 24). 
 
 
Figure 24. UV/Vis absorption spectrum of gold nanoparticles upon adsoption of eGFP by various 
methods. Unmodified, 60 nm diameter gold nanoparticles show a characteristic plasmon resonance peak 
at 526 nm (blue). The plasmon peak is 2 nm red-shifted upon adsorption of eGFP at pH 7.0 (turquoise) 
and upon cross-linking eGFP via DTSSP (orange). A shift to right of 5 nm is obtained, when eGFP is 
adsorbed onto nanoparticles at its pI value (pink). 
 
When the shifts in the plasmon peak positions are compared, it is evident that the biggest shift 
takes place when eGFP is adsorbed onto nanoparticles at its pI value, exceeding even the shift in 
the case of DTSSP usage. The reductions in the peak sizes hint at greater particle aggregation as a 
result of functionalisation. Adsorption at pI value proves to be more effective than the two other 
cross-linking methods, since it demonstrates the smallest peak size reduction. It is noteworthy to 
mention that more efficient adsorption on the nanoparticle fits with the highest fluorescence 
quenching, as explained in the previous part. 
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3.5 Combining the LSPR shift with fluorescence quenching as the basis of a 
bioassay method 
In the literature use of LSPR resonances in biosensors has been reported several times, as well as 
use of fluorescent reporters for the very same purpose. Both methods come with intrinsic 
advantages and disadvantages. The main disadvantage of LSPR based sensors is the 
reproducibility of the nanoparticle synthesis. Most nanoparticles are synthesized by using a 
competitive growth-and-passivation process to control the size of the particle. Such a control is 
very rough. As a result, most nanoparticle products synthesized from wet chemical methods are 
polydispersed, particles with a range of size distribution instead of one uniform size [Huo Q., 
2007]. Since the LSPR peak (and many other properties) of nanoparticles depends strongly on 
size, this variation in the size might impose a problem. Therefore combination of LSPR based 
sensing with fluorescence as a second method might improve the sensitivity of the measurement. 
 
3.5.1 Functionalisation of nanoparticles with antibodies 
Based on the above-mentioned process, a simple scheme was devised. Gold nanoparticles were 
functionalised with antiGFP antibodies, and then their capability to bind to eGFP, the extent of 
plasmon peak shift as well as the fluorescence quenching was measured. As explained above, the 
most straightforward, simplest, and cleanest method for protein binding onto gold nanoparticles 
was determined to be adsorption at the pI value of the proteins. Therefore antibodies were 
adsorbed onto gold at pH 8, the general theoretical pI value for IgG class antibodies. 
 
With a simple method, the functionalisation of nanoparticles with antiGFP antibodies was 
evaluated. Firstly SbsC-eGFP was adsorbed on a silicon wafer, and then the distribution of 
nanoparticles functionalised with antiGFP antibodies was compared with that of non-
functionalised nanoparticles (Fig. 25). 
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Figure 25. Distribution of bare and antibody-linked nanoparticles on a surface with an antigen. 
SbsC-eGFP was adsorbed onto silicon wafers (black patches on both SEM images). AntiGFP antibody 
adsorbed- (A) and non-functionalized (B) gold nanoparticles (white dots, 60 nm diameter) were incubated 
on the wafers. 
 
Clearly, the distribution of the nanoparticles in the two images differs. On the right image, 
nanoparticles seem to be distributed randomly. On the left image nanoparticles demonstrate a 
bigger tendency to cluster on the proteins rather than random distribution; probably due to 
functionalisation with antiGFP antibodies. 
 
Although the microscopy images suggest a successful functionalisation, UV/Vis spectroscopy 
measurements were also carried out, in order not only to provide further evidence to 
functionalisation but also to quantify the amount of antibodies associated with nanoparticles in 
terms of shifts in the plasmon peak. Firstly, the optimum ratio range between the antibodies and 
nanoparticles was inferred by the salt test, as explained previously. The binding was confirmed 
by UV/Vis spectroscopy (section 3.5.2.1). 
 
As seen from the following UV/Vis spectroscopy data (Fig. 26) it is possible to attach antibodies 
onto nanoparticles by adsorbing them at their pI values. The conjugation by this way does not 
only seem to be stable, but also the antibodies seem to retain their functionality, as suggested by 
the SEM images in Fig. 25.  
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3.5.2 Binding capability of antibody-functionalised nanoparticles to respective fluorescent 
proteins in solution 
As outlined, the two components of the bioassay system to be combined are PPR shift and the 
fluorescence change. To this end, the functionalized nanoparticles should be able to bind to the 
respective fluorescent proteins (as explained above they seem to be capable of binding to SbsC-
eGFP on a silicon wafer), furthermore the binding should cause a further shift in the plasmon 
peak, i.e. in addition to the one caused by the adsorption of the antibodies onto nanoparticles, as 
well as a change in the fluorescence intensity of the fluorophore. 
 
3.5.2.1 UV/Vis spectroscopy measurements 
As explained in 3.3.1, the plasmon peak position of metallic nanoparticles depends on size, 
composition, shape, and the dielectric constant of the surrounding medium; and any kind of 
interaction the nanoparticles engage in, represents a change in the dielectric constant of the 
medium, and hence a shift in the plasmon peak. Furthermore this effect is cumulative, i.e. if 
nanoparticles go through a stepwise adsorption, a stepwise shift in the plasmon peak is observed, 
as long as the adsorbing matter is still in a critical distance from the surface of the nanoparticle. 
Therefore, functionalisation of nanoparticles with antibodies and the subsequent attachment to 
the respective antigen is expected to yield a two stepped shift in the plasmon peak. 
 
According to the above mentioned scheme, gold nanoparticles were functionalised with antiGFP 
antibodies by adsorbing them at pH 8.0 and then incubated with defined amounts of the 
respective fluorescent protein.  
 
Table 1. Plasmon peak position of gold nanoparticles after functionalisation with anti-GFP antibodies and 
subsequent incubation with increasing amounts of eGFP 
Antibody concentration (mg/ml) Plasmon peak 
position 0 4*10-5 4*10-4 4*10-3 4*10-2 4*10-1 
0 529.9 530.4 531.4 533.0 533.5 533.8 
0.4 531.3 532.2 533.2 533.0 533.2 533.6 
0.8 532.4 533.4 533.4 533.1 533.5 533.7 
 
eGFP 
conc 
(mg/ml) 1.2 533.1 533.8 534.2 533.5 533.7 533.8 
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Figure 26. Shift in the plasmon peak of gold nanoparticles upon functionalisation with anti-GFP 
antibodies and subsequent incubation with increasing amounts of eGFP. 60 nm diameter gold 
nanoparticles were attached to various concentrations of anti-GFP antibodies (X axis) at pH 8.0 and the 
UV/Vis spectra were measured before the addition of eGFP (blue column) and after each addition of 0.4 
mg/ml of eGFP in a stepwise fashion. The graph is constructed by plotting the peak positions of the 
plasmon peaks. 
 
The expected two-stepped shift in the plasmon peak can be clearly observed in the above graphs, 
when the antibody concentration is within a certain range. According to the graphs this 
concentration is between 4 x 10-5 mg/ml and 4 x 10-4 mg/ml. It is possible that, when the antibody 
concentration is higher than 4 x 10-3 mg/ml, plasmon signal is already saturated, i.e. interaction of 
further material with the gold nanoparticles does not cause an additional shift. Therefore, the 
biggest shift in the first step does not necessarily represent the optimum ratio between the 
antibody concentration and sensor affectivity. Once again, the observed optimum antibody to 
gold nanoparticle ratio for the above mentioned case is around an antibody concentration of 4 x 
10-5 mg/ml and 4 x 10-4 mg/ml. 
 
The second subsequent shifts in the plasmon peak confirm not only the presence of bound 
antibodies on the gold surface, but also that the antibodies retain their functionality, provided that 
eGFP only binds to antibodies. One convenient way to prevent unspecific binding is to block the 
gold surface after the functionalisation with antibodies. Such a blocking agent should fulfil 
certain criteria: First of all, it should be inert, i.e. fluorescent proteins must not interact with the 
blocking agent, but only with the antibodies. Secondly, the plasmon shift caused by the blocking 
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agent must not be as big as that of antibodies as well as the fluorescent protein. Thirdly, it should 
not inhibit the binding of the fluorescent proteins to their respective antibodies. Among the 
blocking agents available and tested, polyvinylpyrrolidone (PVP40) proved to be the most 
suitable. Nanoparticles were first functionalized with antiGFP antibodies, then blocked with 
PVP40, and finally exposed to increasing concentrations of eGFP for the measurement of the 
plasmon peak shift.  
 
 
Figure 27. Shift in the plasmon peak of gold nanoparticles upon functionalisation with anti-GFP 
antibodies, blocking with PVP40, and incubation with increasing amounts of eGFP. 60 nm diameter 
gold nanoparticles were attached to various concentrations of anti-GFP antibodies (X axis) and the 
UV/Vis spectra were measured before blocking with PVP40 and the addition of eGFP (blue column) and 
after first blocking with PVP40 (pink column), and then each 0.4 mg/ml of eGFP were added in a stepwise 
manner. The graph is constructed by plotting the peak positions of the plasmon peaks. 
 
As can be seen from Fig. 27, PVP40 fulfils the above mentioned criteria. Blocking with PVP40 
does not cause a big plasmon shift, and the antibodies seem to retain their ability to bind to eGFP. 
Furthermore, as can be seen from the control column, eGFP demonstrates minimum adsorption 
on the PVP40 layer. 
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3.5.2.2 Fluorescence measurements 
After the binding and the retaining of functionality of the antibodies were confirmed by UV/Vis 
spectroscopy in terms of plasmon peak shifts, the effect of nanoparticles on fluorescence was 
evaluated. The fluorescence signals of the previous constructs were measured using a 
fluorescence plate reader.  
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Figure 28. Change in the fluorescence signal of eGFP upon binding to 60 nm gold nanoparticles 
functionalised with antiGFP antibodies. Y-axis shows the fluorescence signal intensity. 
 
Fig. 28 shows that the extent of quenching does not increase with increasing antibody 
concentration. This indicates that there is indeed a critical antibody to gold nanoparticle ratio, 
which yields not only the optimum plasmon peak shift but also the biggest fluorescence 
quenching. 
 
3.6 Displacement assay with two different fluorophores 
As explained in the previous part, it is possible to functionalise nanoparticles with antibodies and 
to measure the binding of the antibodies to their antigens via plasmon peak shift and 
fluorescence, provided that the antigen has autofluorescence or is coupled to a fluorescent tag. 
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Furthermore, various fluorophores show different behaviours when they are brought in the 
vicinity of nanoparticles, e.g. gold nanoparticles quench the fluorescence of eGFP, whereas the 
fluorescence of rPhiYFP seems to be enhanced (Part 3.3.1). This observation formed the basis for 
the bioassay model explained in the aim of the work. 
 
The model consists of two fluorophores, namely eGFP and cyan fluorescent protein (CFP), both 
HA tagged; and gold nanoparticles functionalised with Roche low or high affinity antiHA 
antibodies. The motivating question was whether it is possible to replace the antigen in such a 
nanoparticle-antibody-antigen construct and to monitor the replacement (please refer to figure 1 
in the Aim). 
 
3.6.1 Interference of eGFP and CFP fluorescence signals  
In order to use two different fluorescent proteins in an exchange type assay, which includes 
measuring fluorescence, it is necessary that the two fluorophores do not quench or enhance each 
other´s signal. In the fluorescent plate reader, the fluorescence emissions of both fluorescent 
proteins were measured at their respective excitation maxima (Fig. 29). 
 
 
Figure 29. Interference of eGFP and CFP fluorescence signals. X stands for 0.5 mg/ml 
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As can be seen from Fig. 29, eGFP and CFP might be good reporter systems: CFP does not give a 
signal when excited at the excitation maximum of eGFP (490 nm). However, eGFP still emits 
when excited at the excitation maximum of CFP (434 nm). 
 
3.6.2 The Assay 
After determining (i) that it is possible to functionally cover nanoparticles with antibodies, (ii) 
that with PVP40 surfaces on nanoparticles that are not occupied with antibodies can be blocked, 
(iii) that depending on the choice of fluorescent reporters, interaction of the fluorophores can be 
minimized, and finally (iv) that all the modifications on the gold surface, i.e. functionalisation, 
blocking, binding of the antigen to the antibody, can be monitored by shifts in the plasmon peak, 
the capability of the assay system was tested. 
 
 
Figure 30. Change in the fluorescence signal upon replacement of HA-eGFP by HA-CFP. The 
change in the fluorescence signal (y-axis) of HA-eGFP bound to high affinity antiHA antibodies adsorbed 
onto 60 nm gold nanoparticles (blue) and lower affinity antiHA antibodies adsorbed onto 60 nm gold 
particles (purple) upon addition of HA-CFP, excited at 490 nm. 
 
The replacement of HA-eGFP by HA-CFP is successful within the antibody concentrations of 4 x 
10-5 and 4 x 10-4, in line with the plasmon shifts described above. The increase in the 
fluorescence signal upon addition of HA-CFP, i.e. replacement of HA-eGFP and its subsequent 
“escape” from quenching is more pronounced when lower affinity antibodies are employed. 
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3.7 In vivo fluorescence studies 
The effect of nanoparticles on certain fluorophores, and a potential use of this phenomenon in a 
bioassay system have been shown. As explained all these experiments were carried out in vitro; it 
is not known if the similar effects can be observed in vivo as well. In an in vitro system the 
interaction partners can be directly bound to each other and the effect can be observed 
(fluorescence and plasmon peak shift in our case), the only possible interference being the 
medium in which the measurements or tests are carried out. On the other hand, the situation is 
different in vivo. First of all, for a successful in vivo investigation, nanoparticles and the 
fluorophores have to be transfected, during which nanoparticles and fluorophore might detach 
from each other. Secondly, after successful transfection, the structures need to be addressed to 
correct compartments, which for instance can be done by targeting antibodies. Thirdly, within the 
cells, even if the structures find their target, they are subject to various ongoing processes within 
the living cells. 
 
In our study, autofluorescent gold nanodots (1-2 nm in diameter) have been embedded in a 
polymeric dendrimer structure coupled to fluorescein (Stp1831). Both fluorescein and 
autofluorescent gold nanodots serve as the reporter for the monitoring of transfection. Fluorescein 
has excitation and emission maxima at 494 nm and 521 nm, respectively. On the other hand the 
autofluorescent gold nanodots have excitation and emission maxima at 270 nm and around 610 
nm respectively. Therefore either no or minimal FRET between the two fluorescent reporters is 
expected. As explained in the introduction part the dendrimer structures have intrinsic 
transfection abilities. This removes the necessity to use an extra transfection reagent, making the 
transfection process simpler and cleaner. 
 
3.7.1 Monitoring of transfection by fluorescence microscopy 
 
As explained above the dendrimer structure used in these trials is coupled to fluorescein, so that it 
is possible to monitor the entry and intracellular fate of the dendrimer structures. Firstly bare 
dendrimer-fluorescein structures (referred to as PPI) were transfected into HeLa cells and 
observed under fluorescent microscope (fig 31) in order to see the transfection efficiency. 
Afterwards, the dendrimers were coupled to autofluorescent gold nanodots (referred to as PPI-
AuND) and then were transfected into HeLa cells, which had been grown to confluence, simply 
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by adding the dendrimers with nanoparticles into the growth medium. Transfection was carried 
out at different concentrations and for different time periods for the optimisation of the process. 
 
 
Figure 31. Transfection of HeLa cells with dendrimers. Fluorescence microscopy images of 
untransfected HeLa cells (A – 40 x magnification) and of HeLa cells transfected with PPI (B – 100 x 
magnification). Both images are merged with bright-field images. 
 
Compared to untransfected HeLa cells, transfected cells clearly demonstrate green fluorescence, 
i.e. fluorescein signal (fig. 31). This, along with the observation that the green signal is 
distributed throughout the cytoplasm of the cells rather than the periphery, indicates successful 
transfection of the dendrimers into the cells. The distribution of fluorescein signal within the 
cytoplasm is further ilustrated by the images taken along the z-axis (fig. 33). As the scanning 
plane moves from top to the bottom of the cells, the distribution of fluorescence within the cells 
increases throughout the cell except for the nucleus, indicating that the PPI-AuND constructs are 
in the cytoplasm. Their capability to deliver the gold nanodots is documented in fig. 32. Cells 
which were transfected only with PPI, do not demonstrate any specific red fluorescence (D-F). 
However, although it is not as high as the green fluorescence, cells transfected with PPI-AuND 
show red fluorescence (A-C). 
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Figure 32. Confocal LSM of HeLa cells upon transfection with PPI-AuND. HeLa cells on glass slides 
were transfected with PPI-AuND and visualized with the red filter for the AuNDs (A), with the green 
filter for fluorescein (B), and both channels were merged (C). HeLa cells were also only transfected with 
PPI and was checked for AuND signal (D), fluorescein signal (E); and both signals were merged (E). All 
images 40 x magnified. 
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Figure 33. Distribution of fluorescence within HeLa cells along the z-axis. HeLa cells transfected with 
PPI-AuND were observed with the green and red filters and images were taken at different depths along 
the z-axis, from the top (1) to the middle of the cells (9). (Confocal LSM – 40 x magnification) 
 
3.7.2 Measurement of the fluorescence signal from the nanoparticles 
Next, HeLa cells were grown in 96-well plates and transfected with the same amount of PPI 
conjugated to autofluorescent gold nanodots for different time periods. The fluorescence of the 
dendrimer, i.e. that of fluorescein and the fluorescent signal of the nanodots were measured by a 
plate reader. The following graph (Fig. 34) shows the nanodot fluorescence signal after such a 
transfection. 
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Figure 34. Quantification and comparison of the nanoparticle fluorescent signals. HeLa cells were 
incubated with the same concentration of PPI or with PPI-AuND, respectively. Cells were incubated for 
the time periods indicated in the x-axis. Cont refers to untransfected cells for blue and yellow columns, or 
wells incubated with DMEM for purple and light blue columns (excitation at 270 nm). 
 
As can be seen from the graph, with increasing transfection time the nanoparticle signal 
increases. Nanoparticle signal obtained from samples treated with unconjugated dendrimer 
(yellow and light blue columns) shows only minimal signal. So it is plausible to assume that 
fluorescein does not interfere with the signal of the gold nanodots. More importantly, the 
fluorescence measurements provide a sound support for the above microscopy results. The signal 
obtained from cells incubated with PPI-AuND is higher than empty plate treated with the same 
structures, indicating that although some interaction between the well surface and the dendrimers 
take place, the interaction between the dendrimers and the cells is higher. 
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4 Discussion 
In the previous chapter, results obtained from studies aiming to use gold nanoparticles as 
photonic markers were presented. What will be further discussed in this chapter are the 
requirements that need to be fulfilled for a successful use of gold nanoparticles and fluorescence 
of certain fluorescent proteins for such an aim. These necessary conditions required include: 
• Determination of how a given type of nanoparticle affects the fluorescence signal of a 
given fluorophore, which depends heavily on the LSPR peak of the nanoparticles and on 
the excitation and emission spectra of the fluorophore. 
• Efficient biofunctionalisation of the nanoparticles, i.e. making the nanoparticles capable 
of binding to biological structures. This includes not only the direct binding of 
fluorophores to nanoparticles, but also binding of antibodies onto nanoparticles for 
biospecific recognition. 
• Determination of the potential of nanoparticles as in vivo reporters and methods of 
intracellular delivery of such nanoparticles. 
   
4.1 Photonic interaction of gold nanoparticles with enhanced green fluorescent 
protein immobilized on a substrate 
 
4.1.1 Obtaining a fluorescent surface 
For the microscopic analysis of the effect of gold nanoparticles on the fluorescence pattern of 
eGFP, we decided to obtain a uniform distribution of eGFP on a microscope slide. It is well 
known that S-layer proteins self-assemble into monomolecular crystalline arrays on various 
artificial solid substrates [Horejs C., et al., 2008]. Therefore, an S-layer/eGFP fusion protein, 
namely SbsC-eGFP, which was already available in the group, was chosen to form a surface with 
eGFP distributed evenly and uniformly. The above mentioned protein was over-expressed in 
bacteria, isolated, and finally adsorbed onto various types of substrates: unmodified glass and 
silicon, chemically modified glass and silicon. The pattern of SbsC-eGFP on those substrates was 
observed by FM, SEM, and AFM. As seen in fig. 14, the height of SbsC-eGFP is around 8 nm, 
which is in accordance with the height reported by Blecha [Blecha A., et al., 2005]. However, the 
S-layer protein does not form a uniform monolayered crystal assembly, but it forms tube-like 
structures. It should be noted that the tubes formed by SbsC-eGFP served well in our 
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experiments, since the tubes are still regularly arranged units, which provide an ease in 
identification. The formation of the tubes is most probably because for the selected bacterial 
strain the monomers already assemble to curved patches in the solution before deposition on the 
substrate can start. There is a driving force for the formation of a curved patch, i.e. it is more 
favourable for the inner part of the tubes not to be exposed to the surface and not to adsorb onto 
glass or silicon [Horejs C., et al., 2008]. 
 
In order to examine, how the surface charge and hydrophilicity influences tube formation, glass 
and silicon substrates were chemically modified. Surface modifications employed were 
functionalisation with APTES, GOPTES, and plasma treatment, and poly-L-lysine. APTES and 
GOPTES modified surface, and poly-L-Lys coated glass bear a positive charge. Plasma 
treatment, on the other hand increases the oxygen atoms on the surface, giving the surface an 
increased negativity and hence an increased hydrophilicity [Wang D.Y., et al., 2007]. In none of 
the above mentioned methods, an entirely SbsC-eGFP covered surface was obtained. In each case 
the regular tube structures were formed. Poly-L-Lys covered glass proved to be too rough for 
AFM, making any structure on it virtually invisible to the AFM tip. Since the aim of the study is 
to observe the effect of nanoparticles on fluorescence, any surface modification should support 
the adsorption and homogenous distribution of nanoparticles on the surface and with the protein, 
as well. In that regard, plasma treatment reduced the number of nanoparticles adsorbing onto the 
surface, possibly due to charge repulsion between negative surface charge of the nanoparticles 
and the plasma treated surface. Therefore plasma treatment was not fitting with our motivations 
to prepare a homogenous distribution of gold nanoparticles and SbsC-eGFP complexes on a 
given substrate.  
 
In addition to SbsC-eGFP, the adsorption behaviour of eGFP on various surfaces was also 
observed. As presented in fig. 16, it was possible to get a surface covering with eGFP on 
GOPTES modified glass, which was closest to uniform. However, regardless of the purity of the 
eGFP preparation, eGFP aggregates were always present. One possible way to get rid of such 
aggregates could be filtering the eGFP suspension with 30 kDa pore sized filters prior to 
adsorption on such treated surfaces. However, as explained above the tubes formed by SbsC-
eGFP were preferred over eGFP because the tube-like structures make it easier for the 
recognition of the protein on the microscope slides. 
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4.1.2 Fluorescence interaction of nanoparticles with immobilized SbsC-eGFP complexes 
Fig. 17 shows AFM and FM images of SbsC-eGFP and gold nanoparticles adsorbed onto 
GOPTES modified glass as discussed above. The SbsC-eGFP tubes and gold nanoparticles were 
identified by measuring their height from the AFM images. Although the association of gold 
nanoparticles with SbsC-eGFP is random, there is at least one SbsC-eGFP tube associated with 
gold nanoparticles at three points (see FM image fig. 17A and AFM image fig. 17B). Please refer 
to the results section for the explanation of the doubling of the structures on fig. 17B. As already 
stated in the beginning of this discussion, it is now well known that metal nanoparticles affect the 
fluorescence in various ways. Upon closer inspection of fig. 17A and B, it is clearly visible that 
the boxed SbsC-eGFP tube does not demonstrate fluorescence around the gold nanoparticles, 
unlike the other SbsC-eGFP tubes. Three reasons for the lack of the fluorescence around the 
nanoparticles can be envisaged: First possibility is the simple shadowing of the fluorescence 
signal by the nanoparticles. However, this is the least likely explanation, since in the 
experimental scheme, the adsorption of the nanoparticles was carried out after the adsorption of 
the SbsC-eGFP tubes, so that the nanoparticles resided on the tubes and FM was carried out from 
beneath. Secondly, using nanoparticles for thermal denaturation of proteins attached to them has 
also been reported in the literature [Takeda Y., et al., 2006]. Therefore it is possible that the local 
heat caused by the strong light absorption by the gold nanoparticles causes the denaturation of 
SbsC-eGFP around the nanoparticles, leading to the observed effect. Thirdly, as detailed in the 
introduction, it is also known that nanoparticles interact with the fluorescence emission and 
excitation of many fluorophores without affecting the structure of the fluorophore, causing a 
quenching or enhancement of the fluorescence, depending on the characteristics of the given 
nanoparticle fluorophore couple. Although fig. 17 demonstrates a reduction in the SbsC-eGFP 
fluorescence signal, it does not suffice to explain whether it is due to denaturation of eGFP or to 
quenching. It should also be noted that, it is not clear from fig. 17 whether the fluorescence signal 
is only reduced to an amount that is below the detection limit of the FM camera or whether it is 
completely extinguished. It is very important to be able to determine the extent of the reduction, 
because a complete lack of fluorescence would hint at denaturation of eGFP around the 
nanoparticles. On the other hand, a partial reduction of the signal would support the hypothesis 
that the signal is only quenched. Therefore, in the next steps, it was decided to work only with 
eGFP in solution and to bind it onto gold nanoparticles under various conditions in order to 
measure the change in the fluorescence signal using fluorescence spectroscopy. 
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An interesting feature of the reduction or diminishing of the eGFP signal of the SbsC-eGFP tubes 
is its localization in a very small area only around the gold nanoparticles, not throughout the 
entire tube. This shows that the effect, regardless of its underlying mechanism, is connected with 
some near field enhancement around the gold nanoparticles and hence limited to a small volume 
around the nanoparticles. It was already reported by Härtling that such an effect is limited to a 
certain area around the nanoparticles [Härtling T., et al., 2007]. Another group reported very 
recently that it is possible to shape the emission spectra of fluorescent molecules by using gold 
nanoparticles and varying the distance between the nanoparticle and the fluorophore [Ringler M., 
et al., 2008]. 
 
A more controlled approach for the interaction of nanoparticles with SbsC-eGFP was to produce 
the nanoparticles on the protein itself. As explained in the methods part, the protein was 
incubated with the non reduced gold atoms, and then the growth solution and reducing agent 
were added in order to grow the gold complexes on SbsC-eGFP into gold nanoparticles. The 
resultant structures were adsorbed onto silicon wafers for SEM (fig. 18) and onto glass slides for 
FM (fig. 19). The SEM images show successful production of uniformly sized nanoparticles on 
SbsC-eGFP. FM images show a strong reduction in the fluorescence signal (fig. 19B) as 
compared to the signal observed from the same amount of SbsC-eGFP without gold 
nanoparticles. Images C and D of fig. 19 demonstrate the fluorescence intensity profiles of A and 
B respectively; made by the MetaVue software, where the fluorescence intensities from images 
which were taken under the same parameters of illumination and recording of emission were 
transformed into numerical values. Each pixel of the fluorescence picture is appointed to such 
number, and an intensity profile is produced according to the values, resulting in a profile with 
higher fluorescence values having greater heights. The observed reduction and no total destroying 
of the fluorescence could be interpreted, that quenching and not denaturation is the relevant 
mechanism. However, it should also be noted that this type of synthesis of nanoparticles causes a 
strain on the protein leading to a deformation as can be observed from the SEM image, i.e. the 
previously observed phenomenon might be caused by a different mechanism than this particular 
case. 
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4.2 Fluorescence interaction of nanoparticles with eGFP in solution 
Due to the above-mentioned reasons, and in order to see the difference, if any, between solution 
systems or adsorbed-on-substrate based systems, eGFP was adsorbed onto nanoparticles under 
different conditions. Afterwards the fluorescence signal as well as the shifts in LSPR upon 
binding were measured. 
 
4.2.1 Adsorption of eGFP onto AuNPs 
One of the simplest and most straightforward methods for attaching proteins to nanoparticles is to 
adsorb them at their pI value [Takeda Y., et al., 2006]. To this end, the pI value of 5.5 was 
calculated for eGFP and experimentally confirmed using isoelectric focusing. The same was 
carried out for rPhiYFP, and a pI of 6.5 was measured. 
 
The efficiency of binding eGFP onto nanoparticles at pH 5.5 and 7.0 was tested. As shown in fig. 
20, the supernatant fractions of the samples incubated at pH 5.5 does not produce an eGFP band 
on the Western blot. Considering that the centrifugation speed was enough to sediment 
nanoparticles but not high enough to sediment eGFP alone, it is concluded that eGFP molecules 
must have been adsorbed onto nanoparticles and sedimented together with them. However, this 
does not necessarily mean that no eGFP is bound on the nanoparticles at pH 7.0. In order to 
determine the amount of the eGFP adsorbed onto nanoparticles, nanoparticles sedimented by 
centrifugation need to be resuspended and detached from the eGFP, e.g. by treatment with SDS. 
The nanoparticles used in this study, however, could not be completely resuspended upon 
centrifugation. Moreover, when samples containing nanoparticles were loaded and run on 
polyacrylamide gels, nanoparticles either prevented the entry of the proteins into the gel matrix, 
or interfered with their running pattern and the results were not reproducible. 
 
As explained in the introduction part, one of the factors that determine the position of the LSPR 
peak is the dielectric constant of the medium of the nanoparticles. Binding of any type of 
molecule (e.g. capping agent, polymer, protein, etc.) to the nanoparticle surface represents a 
change in the dielectric constant and therefore manifests itself as a change in the plasmon peak. 
The change comes in various forms, either as peak broadening and/or reduction in the height of 
the peak, which is indicative of nanoparticle aggregation upon protein binding, or as a red shift, 
or both. Therefore, we monitored the changes in the plasmon peak upon adsorption of eGFP at 
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various pH values in terms of changes in the LSPR peak (Fig. 21). The most prominent shift is 
obtained when eGFP is adsorbed onto gold nanoparticles at pH 5.5, in accordance with the results 
explained above. Therefore, the most effective adsorption of eGFP onto gold nanoparticle takes 
place at pH 5.5 and refers to biggest number of eGFP molecules adsorbed. It should be noted that 
for all of the pH values the change in the LSPR peak pattern was a red-shift, lack of a significant 
peak broadening indicates that there was no significant agglomeration. 
 
In another trial we compared the efficiency of adsorbing eGFP versus cross-linking eGFP onto 
gold nanoparticles. Equal amounts of eGFP were incubated with gold nanoparticles at neutral pH, 
at the isoelectric point of eGFP, and cross-linked to gold nanoparticles by a commercially 
available cross-linker, namely DTSSP. Fig. 24 shows the changes in the LSPR peak positions. 
The biggest shift is obtained when eGFP is adsorbed onto nanoparticles at pH 5.5. This confirms 
that proteins not bearing a net charge adsorb more efficiently onto nanoparticles because charge 
repulsion is not present. The shifts in the case of neutral pH and DTSSP cross-linking were the 
same and less than that of pH 5.5. Furthermore, there was a clear reduction in the height of the 
LSPR peak in the case of DTSSP, suggesting agglomeration. This is most probably because more 
than one DTSSP can bind to one eGFP molecule leading to the formation of nanoparticle-protein 
complexes, which agglomerate. 
 
Therefore, it is more straightforward, cleaner, simpler, and more efficient to bind globular 
proteins, such as eGFP onto gold nanoparticles at their pI values rather than using DTSSP, which 
is not only less efficient but also leads to the aggregation of nanoparticles. Furthermore, as the 
number of reagents used in the binding process increases, the risk of creating a shift in the LSPR 
peak due to a change in the refractive index or dielectric constant of the medium increases. 
 
4.2.2 Evaluation of the effect of nanoparticles on eGFP and rPhiYFP in solution  
The measurement of the change in the fluorescence signal of the fluorophores upon adsorption 
onto gold nanoparticles was carried out in order to confirm and quantify the effect discussed in 
chapter 4.1. Furthermore, in addition to the confirmation of that effect, the change in the extent of 
fluorescence reduction upon adsorbing the fluorophores at different pH values would confirm the 
efficiency of binding at pI value. 
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In these measurements two fluorescent proteins, namely eGFP and rPhiYFP and two different 
types of nanoparticles, namely gold nanoparticles and gold/silver alloyed nanoparticles were 
used. Please refer to the appendix for the respective emission and excitation spectra of the 
fluorophores and the absorption spectra of the metal nanoparticles. 
 
Fig. 22 shows the results of an experiment, where the fluorescence of eGFP was measured at 
different pH values (blue columns), then at the same pH values after adsorbing onto gold 
nanoparticles (red columns), and finally again at the same pH values after adsorbing onto 
gold/silver alloyed nanoparticles (yellow columns). First of all, there were changes in the eGFP 
fluorescence signal at varying pH values, which is a normal event considering that the pH of the 
medium is one of the main factors affecting the fluorescence of a fluorophore [Kneen M., et al., 
1998]. Secondly, at each pH value, when gold nanoparticles were present, the eGFP fluorescence 
signal was reduced. This suggests that even at pH 7.0 a certain amount of eGFP is bound to the 
nanoparticles. However, the greatest reduction was at the pI value of eGFP, i.e. at pH 5.5. This 
observation fits well with the expectation that the most efficient adsorption of eGFP onto gold 
nanoparticles was at its pI value and therefore the biggest change in its fluorescence signal would 
be observed at that pH. 
 
The conclusion to be drawn from that experiment is not only the adsorption behaviour of eGFP. 
The fluorescence signal of eGFP was either not reduced at all, or not reduced as much when it 
was adsorbed onto gold/silver alloyed nanoparticles. Even a slight enhancement could be 
observed at pH 7.0. This observation rules out the denaturation of eGFP being the cause of the 
reduction in fluorescence. eGFP has an excitation maximum at 490 nm and an emission 
maximum at 520 nm, which means that the excitation wavelength for the above explained 
experiment was 490 nm. As stated in the appendix, the gold nanoparticles and alloyed 
nanoparticles have LSPR peak at 520 nm and 490 nm, respectively. As explained in the 
introduction, the LSPR peak corresponds to the wavelength, at which the surface electrons of 
nanoparticles absorb the most. Therefore, theoretically alloyed nanoparticles absorb more than 
gold nanoparticles and have a higher capacity of releasing the absorbed energy as heat. If the 
reason for the reduction in fluorescence had been heat denaturation of eGFP by nanoparticles, the 
reduction would have been more pronounced in the case of alloyed nanoparticles, with their 
higher absorbance at 490 nm. It is more likely, that the reduction was due to a FRET-like energy 
Discussion 
88 
transfer, where the fluorescence emitted by eGFP at 520 nm was absorbed by the gold 
nanoparticles which absorb strongly at that wavelength. 
 
In order to support the above conclusion, the behaviour of rPhiYFP upon adsorbing onto gold 
nanoparticles was investigated. The fluorescence signal of rPhiYFP was measured at neutral pH 
and at its pI value (pH 6.5). Then it was incubated with gold nanoparticles at neutral pH and at its 
pI, and its fluorescence signal was measured. The outcome is presented in fig. 23. As in the case 
of eGFP, rPhiYFP fluorescence signal was reduced at its pI value. However, contrary to the 
eGFP case, addition of gold nanoparticles led to an enhancement of the rPhiYFP fluorescence 
signal, with the extent of enhancement being higher at pH 6.5. Please refer to the appendix for the 
excitation and emission spectra of eGFP and rPhiYFP, as well as the plasmon peak positions of 
the nanoparticles. If the underlying reason of reduced eGFP signal had been denaturation by gold 
nanoparticles, a similar behaviour would have been observed here, as well. Therefore, it was 
concluded that the reduction is mainly due to a FRET-like energy transfer between the 
fluorophore and nanoparticle. 
 
Although the conclusion drawn from above mentioned experiments is favouring an interaction 
mechanism between a fluorescent proteins and nanoparticles other than protein denaturation, this 
possibility cannot completely be ruled out. Light absorption and heat dissipation by a 
nanoparticle possibly takes more time. In order to rule out denaturation, parameters required for 
such a phenomenon could be determined by exposing the conjugates longer to irradiation times 
and/or higher intensity, e.g. by changing the laser. However, with increasing irradiation time the 
risk of bleaching the fluorophore increases. Therefore, it would make sense to use for such 
measurements either bleaching-resistant fluorescent proteins, or proteins that are not fluorescent 
at all; for instance enzymes, of which the activity can easily be monitored. 
 
While being able to denature proteins locally offers a great promise in medicine; modifying 
fluorescence of fluorescent tags without denaturing or causing damage to the surroundings can 
prove to be valuable, especially in bioimaging and biosensing applications employing 
fluorescence. In such measurements, the sensitivity of the approach is a direct function of the 
signal obtained from the fluorescent reporter. Therefore, being able to enhance, e.g. the 
enhancement of rPhiYFP fluorescence by gold nanoparticles, or to quench, e.g. the quenching of 
Discussion 
89 
eGFP fluorescence by gold nanoparticles, the fluorescence of tags can prove to be important for 
instance for increasing the signal to noise ratio or to switch off one reporter whilst switching on 
another. 
 
4.3 Functionalisation of nanoparticles with antibodies 
As stated in the introduction of the thesis, one of the aims of this study is to demonstrate the 
potential of nanoparticles and the effect they have on fluorescence of certain fluorophores in 
biosensing. For that purpose, one of the crucial steps is to attach antibodies onto gold 
nanoparticles. Additionally, during this process antibodies need to retain their functionality. 
 
For the functionalisation of gold nanoparticles, an approach similar to the adsorption of eGFP 
onto gold nanoparticles was adopted. Commercially available antiGFP antibodies were incubated 
at 8.0, the general theoretical pI value for IgG class antibodies [Hamilton, R.G., 1990]. The 
functionality of gold nanoparticle attached antibodies was tested on SbsC-eGFP adsorbed onto 
silicon wafers. SbsC-eGFP was adsorbed onto silicon wafers and treated with gold nanoparticles 
functionalized with antiGFP antibodies and with non-functionalised nanoparticles. Afterwards, 
the distribution of the nanoparticles was observed by SEM (fig. 25). Fig. 25 shows a distribution 
difference between functionalised and non-functionalised nanoparticles, where functionalised 
nanoparticles seemed to bind to SbsC-eGFP patches on the silicon wafer and non-functionalised 
ones did not. 
 
In order to support the SEM images and to quantify the antibody binding onto gold nanoparticles, 
LSPR peak shifts were measured (fig. 26).  There, we see that the shift in the LSPR peak is 
greater for higher antibody concentrations. Furthermore, upon addition of eGFP further shift is 
achieved. However, it is not possible to ascertain the increase in the other cases to binding of 
antiGFP antibodies to eGFP because there is an LSPR shift when eGFP is added to nanoparticles 
not functionalized with antibodies. In order to prevent that, the same structures were prepared 
with an additional step of blocking immediately after the addition of antibodies (fig. 27). Among 
the tested blocking agents PVP40 turned out to be the best suited to our needs, because it did not 
cause a big shift in LSPR peak in most of the cases (lack of LSPR peak  shift after blocking for 
the antibody concentrations 0 mg/ml and 4 x 10-5 mg/ml). eGFP did not seem to adsorb onto it 
very strongly (note the difference between the shift after addition of eGFP to naked nanoparticles 
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and to the nanoparticles functionalised with 4 x 10-5 mg/ml of antiGFP antibodies). It should be 
noted that antibody concentrations higher that 4 x 10-4 mg/ml and an eGFP concentration of 0.4 
mg/ml were enough to saturate the LSPR peak shift. However, the system can still be used for 
detection of eGFP at concentration less than 0.4 mg/ml, with PVP40 as a safe blocking agent. 
 
In the next step, the procedures for functionalisation of the gold nanoparticles were repeated and 
the change in eGFP fluorescence was measured. As stated earlier, as the amount of gold-bound 
eGFP increases, a reduction in the fluorescence signal is expected. Figure 28 shows the results of 
such a measurement where the degree of quenching did not increase linearly with increasing 
antibody concentration, which supports the conclusion that there is a critical antibody 
concentration; and in our case that ratio turned out to be 4 x 10-5 mg/ml. Note that the columns at 
the first lane in x-axis do not contain nanoparticles. 
 
4.4 Utilisation of the above systems in an exchange type assay 
As the name suggests, for an exchange type assay at least two antigens are required. Two HA-
tagged fluorescent proteins, namely HA-CFP and HA-eGFP, were already available in the group. 
Therefore the FRET between the two fluorophores was investigated as the first step. The 
excitation and emission spectra and maxima of both proteins are supplied in the appendix part. 
Three solutions containing HA-eGFP, HA-CFP, and both were excited at their excitation 
maximum and at each other’s excitation maxima, followed by measuring their emissions (figure 
29). According to the graph, there is a FRET between CFP and eGFP if the mixture is excited at 
434 nm and emission is recorded at 520 nm, which is expected considering emission maximum 
of CFP lies close to the excitation maximum of eGFP. On the other hand if excitation is carried 
out at 490 nm, there is no FRET between the two fluorophores. 
 
The assay was performed in a very similar way to the gold nanoparticle functionalisation 
experiments explained above. Gold nanoparticles were functionalised with commercially 
available antiHA antibodies and commercially available high affinity antiHA antibodies from the 
same supplier, followed by blocking the surfaces with PVP40. Then the functionalised 
nanoparticles were incubated with HA-eGFP, and the fluorescence signal was measured. Finally, 
the complexes were incubated with HA-CFP and the fluorescence signal was measured once 
again. Fig. 33 shows the change in HA-eGFP after addition of HA-CFP. First of all, after addition 
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of HA-CFP, HA-eGFP signal increases at each antibody concentration as compared to the signal 
coming from the control. This suggests that the displacement of HA-eGFP by HA-CFP takes 
place. The fluorescence signal is expected to increase when HA-eGFP is replaced by HA-CFP, 
because eGFP is no longer quenched by the nanoparticles. This is further supported by the fact 
that at antibody concentrations 4 x 10-5 mg/ml and 4 x 10-4 mg/ml the increase is higher for the 
lower affinity antiHA antibodies. The very high increase in the fluorescence signal for the higher 
antibody concentrations and a lack of difference between the lower affinity and higher affinity 
antibodies suggest saturation.  
 
Together with the results from functionalisation studies, antibodies seem to retain their 
functionality and specificity when conjugated to nanoparticles. Also, as exemplified by the HA-
eGFP and HA-CFP exchange system, it is possible to use the quenching of a fluorophore as a 
reporter for an exchange type assay, where the exchange of antigens leads to the release of a 
quenched fluorophore from the nanoparticle and a concomitant increase in the fluorescence 
signal. However, before this basic observation can be integrated into a bioassay, parameters such 
as kinetics of the exchange and stability of gold-antibody complexes need to be determined. Once 
such a system is fully characterised, it can be advantageous to many current systems because the 
gold nanoparticles also offer LSPR shifts as reporters of binding events, and theoretically the 
combination of fluorescence measurements with LSPR peak measurements can increase the 
sensitivity of the assay.  
 
4.5 In vivo fluorescence studies 
As stated in the introduction part, autofluorescent metal nanoparticles offer numerous advantages 
over classical fluorescent proteins and dyes. First step in the usage of autofluorescent gold 
nanoparticles is their intracellular delivery. As explained in the introduction, one of the newly 
emerging intracellular delivery agents is the dendrimers. Autofluorescent gold nanoparticles, with 
an excitation max at 270 nm and emission maximum at 610 nm (for respective spectra, please 
refer to the appendix) were embedded into PPI dendrimers. Furthermore, for an additional means 
for monitoring the intracellular delivery complex, dendrimer molecules were labelled with 
fluorescein, a fluorescent dye that has excitation max at 494 nm and emission max at 521 nm. 
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Results of the transfection experiments carried on the 96-well plate (figure 34) indicate that the 
delivery structure interacts with the surface of the wells, because a signal is also obtained from 
the wells that did not contain any HeLa cells, but were incubated with PPI-AuNDs. However, at 
every time point, the signal obtained from the wells containing cells is higher than that of the 
empty wells, which does not necessarily indicate a successful transfection. Yet, it is clear that the 
delivery complex interacts with the cells more than it adsorbs to the walls of the 96-well plate. 
 
In order to confirm the intracellular delivery of the structures, a series of confocal LSM 
experiments were carried out. Firstly, HeLA cells were incubated with fluorescein labelled 
dendrimer (PPI), and the fluorescein signal from the treated cells was compared with that of 
untreated cells (fig. 31). Since the images were taken from a middle plane of the cells, it can be 
concluded from fig. 31, that the PPI enters the cell and is distributed in the cytoplasm. Secondly, 
HeLa cells were transfected with PPI-AuND and only PPI. The fluorescence images of AuND 
and PPI were separately taken and then merged (fig. 32). In the red channel there was a clear 
AuND signal coming from the cells transfected with PPI-AuND. In the case of the cells 
transfected with PPI, the only red signal is due to back-scattering from the glass surface and is 
definitely not associated with the cells. The fluorescence signal from the green channel shows the 
distribution of the dendrimer within the cytoplasm. Nuclei of the cells both transfected with PPI-
AuND and PPI are distinguishable, once again supporting the fact that the dendrimers are 
successful in internalisation. Furthermore, the green signal is distributed throughout the 
cytoplasm, indicating a minimum aggregation of the delivery complexes. When the images from 
both channels are merged, it is clear that the red signal and the green signal from the cells 
transfected with PPI-AuND overlap. On the other hand the two signals, namely the red signal 
coming from back-scatter and green coming from fluorescein, for the cells transfected only with 
PPI do not overlay. This leads to the conclusions, that the dendrimers are successful in 
transfection and the autofluorescent gold nanoparticles are good candidates for being used as 
inorganic fluorophores in vivo. Fig. 33 provides more support to the fact that the fluorescence 
signal is coming from the cytoplasm, but not from the cell surface, i.e. the structures are 
internalised. 
 
In addition to the internalization of the PPI-AuND, the success of the transfection also depends 
on the stability of the complexes within the cells. It should be noted that all the images presented 
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here were from cells transfected for 4 hours. In almost all of the cases the cells started dying after 
5 to 6 hours of transfection. This makes this particular dendrimer suitable for short-term 
transfection studies. It should be also noted that the structures did not lose stability during 4 
hours. 
 
Although the above described and discussed experiments show that nanoparticles are promising 
intracellular markers, it is still important to determine numerous parameters regarding their 
efficiency and safety. As addressed above, one of the most critical questions is the stability of the 
dendrimer nanoparticle complexes. Additionally, especially in the case of live imaging, modes of 
transfection, intracellular fate, and toxicity of the nanoparticles and the dendrimers need to be 
determined before applications. However, once such questions are answered and safety issues are 
resolved, nanoparticles seem to be promising alternatives to conventional fluorescent dyes and 
proteins. Dendrimers on the other hand provide a good link to biofunctionalisation for 
nanoparticles, since they can be linked to antibodies or other specific biological recognition 
elements for targeting nanoparticles to intracellular locations. 
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5 Summary 
Metal nanoparticles have recently gained popularity in many research areas due to their nanosize-
related properties. Depending on the size of the metal nanoparticle, their mode of interaction with 
electromagnetic radiation and the outcome of this interaction vary; in turn the effect exerted on a 
protein which is conjugated to a nanoparticle varies, because different sized nanoparticles 
demonstrate different modes of energy transfer with electromagnetic radiation and molecules 
conjugated to them. This versatility opens the way for various different applications (shortly 
summarized in fig. 35). Very small cluster with sizes around 1 – 1.2 nm tend to get excited by 
incident light and emit fluorescence, whereas larger nanoparticles absorb the incoming light very 
strongly due to their LSPR. 
 
 
Figure 35. Size-dependent properties of metal nanoparticles, and their uses within the frame of this 
work. 
 
In this study we observed the outcomes of the interaction between two types of nanoparticles, 
namely gold and gold/silver alloyed nanoparticles with the fluorescence emission of two 
fluorophores, namely eGFP and rPhiYFP. The first observed effect of gold nanoparticles on the 
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fluorescence emission of eGFP was a reduction of eGFP signal around the nanoparticles verified 
by fluorescence and atomic force microscopy. In order to determine whether the observed effect 
was due to quenching of the eGFP fluorescence by the gold nanoparticles or due to local 
denaturation of the eGFP molecules around nanoparticles (in turn caused by heat production due 
to absorbed light), the fluorescence emission of eGFP adsorbed onto gold nanoparticles was 
measured in solution. In addition to verifying the efficiency of adsorbing proteins onto gold 
nanoparticles at their isoelectric point as a simple means for protein-nanoparticle conjugate 
preparation, the measurements confirmed a reduction of eGFP fluorescence. The same reduction, 
however, was not observed, when either eGFP was adsorbed onto gold/silver alloyed 
nanoparticles, or rPhiYFP was adsorbed onto gold nanoparticles. Therefore, we conclude that the 
reason for the reduced fluorescence is not denaturation of the protein species by the heat 
produced due to the strong absorption of nanoparticles at their LSPR peaks, since rPhiYFP 
fluorescence is not reduced when adsorbed onto gold nanoparticles (on the other hand it was 
enhanced to a certain extent). Furthermore, since the same reduction is not observed with eGFP 
adsorbed onto gold/silver alloyed nanoparticles, we conclude that the reason of the reduction is 
quenching by a FRET-like mechanism, where light emitted by eGFP at around 520 nm is 
absorbed strongly by the neighbouring gold nanoparticles. 
 
The above mentioned quenching/enhancement phenomenon can be utilised in various areas 
ranging from microscopy to biosensing. In order to exemplify one such application, a bioassay 
was designed, in which the replacement of an eGFP tagged antigen bound to gold-antibody 
conjugates was replaced by the addition of the antigen with a different tag lead to an increase in 
the eGFP fluorescence as a result of the exchange of antigen and subsequent separation of eGFP 
from the gold nanoparticle to stop quenching. We were able to get such an assay working, i.e. we 
could observe an increase in the eGFP fluorescence when eGFP-HA bound to antiHA antibody-
gold nanoparticle conjugates was replaced by another HA tagged protein. This type of an assay 
provides another advantage: It is possible to monitor the replacement and binding events using 
the shifts in LSPR peak position as the gold bound species interchange. This observation can be 
further utilised as the basis of a proper biosensor combining the change in fluorescence and shifts 
in LSPR peak for an increased sensitivity. 
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In order to demonstrate the versatility of gold nanoparticles in biological research, we also tried 
to use gold nanoparticles as intracellular markers. For that end, autofluorescent gold 
nanoparticles were delivered into cultured HeLA cells by using oligosaccharide-modified 
poly(propyleneimine) dendrimers (PPI). Gold nanoparticles were embedded in the dendrimer 
structures and then transfected. By using confocal laser scanning microscopy, we were able to 
visualize gold nanoparticles within the cells, which seemed to be widely distributed, i.e. not 
confined to a certain organelle. Therefore, as a future prospect, antibodies targeted with such gold 
nanoparticles present a great potential for in vivo targeting studies. Furthermore, these 
experiments also presented the efficiency of the above mentioned dendrimers as intracellular 
carriers of various molecules. 
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Appendix 
 
Preparation of 0.1 M potassium phosphate buffer  
Table 2. Volume ratio of solution A and B for the desired pH 
pH Solution A (ml) Solution B (ml) pH Solution A (ml) Solution B (ml) 
5.7 93.5 6.5 6.9 45.0 55.0 
5.8 92.0 8.0 7.0 39.0 61.0 
5.9 90.0 10.0 7.1 33.0 67.0 
6.0 87.7 12.3 7.2 28.0 72.0 
6.1 85.0 15.0 7.3 23.0 77.0 
6.2 81.5 18.5 7.4 19.0 81.0 
6.3 77.5 22.5 7.5 16.0 84.0 
6.4 73.5 26.5 7.6 13.0 87.0 
6.5 68.5 31.5 7.7 10.5 90.5 
6.6 62.5 37.5 7.8 8.5 91.5 
6.7 56.5 43.5 7.9 7.0 93.0 
6.8 51.0 49.0 8.0 5.3 94.7 
 
Preparation of 0.1 M potassium acetate buffer  
Table 3. Volume ratio of solution A and B for the desired pH 
pH Solution A (ml) Solution B (ml) 
3.6 46.3 3.7 
3.8 44.0 6.0 
4.0 41.0 9.0 
4.2 36.8 13.2 
4.4 30.5 19.5 
4.6 25.5 24.5 
4.8 20.0 30.0 
5.0 14.8 35.2 
5.2 10.5 39.5 
5.4 8.8 41.2 
5.6 4.8 45.2 
Appendix 
107 
 
LSPR peak of the gold and gold/silver alloyed nanoparticles 
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Figure 36. LSPR peak of 60 nm diameter Au nanoparticles (blue) at 520 nm and of 30 nm diameter 
Au/Ag alloyed nanoparticles (pink). 
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Emission and excitation spectra of the autofluorescent Au nanoparticles and fluorescein 
Note that these nanoparticles have an average diameter of 2 nm and therefore do not exhibit 
LSPR peak. Therefore, only the fluorescence spectra are provided. Also, the dendrimer structures 
are labelled with fluorescein, so the green fluorescence signal measured from the dendrimers 
actually refer to the signal from fluorescein. 
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Figure 37. Excitation spectra of the autofluorescent Au nanoparticles embedded in dendrimer (dark red 
line) and of dendrimer (purple line). The peak at 270 nm corresponds to the excitation peak of AuNPs and 
the peak around 490 to the fluorescein. 
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Figure 38. Emission spectra of the autofluorescent Au nanoparticles embedded in dendrimer (green line) 
and of dendrimer (red line). The peak at 610 nm corresponds to the emission peak of AuNPs and the peak 
around 520 to the fluorescein. 
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Emission and excitation spectra of the fluorescent proteins  
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Figure 39. Excitation (blue line) and emission spectra (green line) of eGFP. 
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Figure 40. Excitation (green line) and emission spectra (yellow line) of rPhiYFP. 
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CFP fluorescence excitation/emission spectra
0
20
40
60
80
100
300 400 500 600 700
Wavelength, nm
Fl
uo
re
sc
en
ce
em
ex
 
Figure 41. Excitation (navy blue line) and emission spectra (turquoise line) of CFP 
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Figure 42. Overlayed excitation and emission spectra of the three fluorophores used. Normalisation of the 
relative intensities was carried out by Origin (OriginLab Corporation). 
 
Table 4. Excitation and emission maxima of fluorescent proteins 
Protein   excitation max (nm)   emission max (nm) 
eGFP    490     520 
rPhiYFP   515     527 
CFP    434     474 
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High yield production of fluorescent proteins 
For the analysis of the effect of metallic nanoparticles on biological matter, eGFP was chosen as 
the initial model. In order to produce eGFP in high yield a glutathione-S-transferase (GST)-eGFP 
hybrid protein was engineered. The GST tag allows easy isolation of the fusion protein by use of 
glutathione beads, as explained previously. Another eGFP fusion protein, namely SbsC-eGFP, 
was chosen as a second model because of the intrinsic ability of this S-layer protein to form 
uniform tube-like structures on surfaces in vitro [Blecha et al., 2005]. By taking advantage of this 
property of SbsC, it should be possible to obtain a protein assembly on a surface with uniformly 
distributed eGFP molecules for microscopic analysis. 
 
Cloning of GST-eGFP 
DNA sequence of GST was PCR amplified from a pGEX3 vector and then cloned into the pET-
17b expression vector which contains the eGFP gene under the control of the T7 promoter. The 
resulting construct was cloned into E.coli strain BL21 DE3α. Transformants were selected on LB 
medium containing Ampicillin. 
 
Expression of GST-eGFP and isolation of eGFP 
A correct transformant was grown overnight in a pre-culture and then inoculated into LB, 
whereby expression was induced by IPTG. To find the optimum induction time aliquots from the 
cell suspension at different incubation times were taken at time intervals, protein was isolated, 
and analysed by electrophoresis on a 12% SDS gel. The presence of the fusion protein was 
verified by Western blot analysis. The highest expression was observed after overnight 
incubation, as evidenced by the strongest eGFP band (fig 43). eGFP was separated from GST via 
acTEV protease digestion (fig 44). 
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Figure 43. Kinetics of GST-eGFP expression. Lysates from uninduced culture (lane 1), o/n grown 
culture (lane 2), cultures grown for 8 (lane 3), 6 (lane 4), 4 (lane 5), and 2 (lane 6) hours were analysed by 
SDS-PAGE and detected with antiGFP antibodies. 
 
 
 
Figure 44. Efficiency of AcTEV protease digestion under different conditions for the isolation of 
eGFP. GST-eGFP fusion protein was digested at room temperature for one hour (RT 1hr), at 4ºC for one 
hour (4ºC 1hr), and at 4ºC overnight (4ºC o/n). Lanes 1, 4, and 7: undigested samples. Samples digested 
with protease in the presence (lanes 2, 5, and 8) or absence (lanes 3, 6, and 9) of protease inhibitor 
(AEBSF). 
 
Theoretical pI value of eGFP was calculated using Swissprot to be 5.2. A pI value of 5.1 was 
verified experimentally via 2D-SDS-PAGE, with isoelectric focusing in the 1st separation (data 
not shown).  
 
Expression and isolation of SbsC-eGFP 
E.coli strain BL21 DE3α was transformed with the expression vector pet-17b containing SbsC-
eGFP[Blecha A., 2005] and used for the expression of the respective protein. The isolation of the 
correct protein was verified by 12% SDS-PAGE followed by Western blotting and detection with 
antiGFP antibodies (data not shown). 
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